- Published on
Symptoms and Signs – Differential Diagnosis of muscle weakness
Myopathy, also known Muscle weakness is identified through the observation and assessment of the strength of a specific muscle or muscle group. It may arise from a dysfunction in the cerebral hemispheres, brainstem, spinal cord, nerve roots, peripheral nerves, myoneural junctions, or within the muscle itself. Muscle weakness arises from specific neurological, musculoskeletal, metabolic, endocrine, and cardiovascular conditions; as a reaction to particular medications; and following extended immobility.
Medical History and Physical Assessment
Commence by identifying the site of the patient's muscular deficiency. Inquire whether he experiences challenges with particular motions, such as standing up from a chair. Inquire when he first observed the weakness; ask him if it exacerbates with physical activity or as the day advances. Inquire about associated symptoms, including musculoskeletal discomfort, altered sensory perception, and exhaustion. Gather a medical history, emphasizing chronic conditions such as hyperthyroidism; musculoskeletal or neurological issues, including recent injuries; a familial history of chronic muscle weakness, particularly in men; and substance use, including alcohol and drugs. Concentrate your physical assessment on assessing muscular strength. Assess all primary muscular groups bilaterally. . During testing, ensure that the patient's effort remains consistent; if it does not, consider the possibility of pain or other hesitance to exert effort. If the patient reports pain, alleviate or cease testing and have him attempt the exercises once more. Note that the patient's dominant arm, hand, and leg have greater strength than their nondominant equivalents. In addition to assessing individual muscle strength, evaluate the range of motion (ROM) at all principal joints (shoulder, elbow, wrist, hip, knee, and ankle). Additionally, assess sensory function in the affected regions and evaluate deep tendon reflexes (DTRs) bilaterally.
Etiological Factors
Amyotrophic lateral sclerosis (ALS). Amyotrophic lateral sclerosis (ALS) generally initiates with muscular weakness and atrophy in one hand, which swiftly disseminates to the corresponding arm and then to the other hand and arm. Ultimately, these consequences extend to the trunk, neck, tongue, larynx, pharynx, and legs; advancing respiratory muscle weakness results in respiratory insufficiency. Anemia. Muscle weakness and weariness of varying severity are intensified by exertion and momentarily alleviated by rest. Additional indications and symptoms encompass pallor, tachycardia, paresthesia, and a propensity for bleeding.
Intracranial neoplasm
The manifestations of muscle weakness differ based on the tumor's location and dimensions. Related symptoms encompass headache, vomiting, diplopia, reduced visual acuity, altered state of awareness (LOC), pupillary alterations, lower motor strength, hemiparesis, hemiplegia, decreased sensations, ataxia, seizures, and behavioral modifications.
Guillain-Barré syndrome
Rapidly advancing, symmetrical weakness and discomfort escalate from the feet to the arms and facial nerves, potentially culminating in complete motor paralysis and respiratory failure. Accompanying findings encompass sensory loss or paresthesia, muscle flaccidity, absence of deep tendon reflexes, and tachycardia. Bradycardia, variable hypertension and orthostatic hypotension, diaphoresis, incontinence of bowel and bladder, facial diplegia, dysphagia, dysarthria, and hypernasality.
Intervertebral disc herniation
Compression of nerve roots results in muscular weakening, disuse, and ultimately, atrophy. The principal symptom is intense lumbar pain, perhaps extending to the buttocks, legs, and foot, typically unilateral. Reflexes may be diminished, and sensory alterations may also manifest.
Hypercortisolism
Hypercortisolism can lead to muscular weakness and ultimately atrophy of the limbs. Cushingoid characteristics encompass buffalo hump, moon facies, truncal obesity, purple striae, atrophic skin, acne, hypertension, weariness, hyperpigmentation, easy bruising, impaired wound healing, and diaphoresis. The male patient may experience impotence; the female patient may display hirsutism and menstruation abnormalities.
Myasthenia gravis
The primary signs of myasthenia gravis are gradually growing skeletal muscular weakening and tiredness. Generally, weakness is slight upon awakening but intensifies over the day. Initial indicators comprise diminished eye closure, ptosis, and diplopia; expressionless, mask-like facial appearance; challenges in mastication and deglutition; nasal reflux of fluids accompanied by hypernasality; and a drooping jaw with a bobbing head. Involvement of the respiratory muscles may ultimately result in respiratory failure.
Osteoarthritis
Osteoarthritis is a chronic condition that results in gradual muscular disuse and weakness, ultimately leading to atrophy.
Parkinson's disease
In Parkinson's disease, a degenerative illness, muscle weakness is present alongside rigidity. Associated symptoms comprise a unilateral pill-rolling tremor, propulsive gait, dysarthria, bradykinesia, drooling, dysphagia, masklike facies, and a high-pitched, monotonous voice. Trauma to peripheral nerves. Extended pressure on or damage to a peripheral nerve results in muscular weakening and atrophy. Additional findings encompass paresthesia or sensory deficits, discomfort, and the absence of reflexes innervated by the affected nerve.
Potassium dysregulation
Hypokalemia may result in transient generalized muscle weakness, potentially accompanied by nausea, vomiting, diarrhea, impaired cognition, leg cramps, reduced reflexes, malaise, polyuria, dizziness, hypotension, and arrhythmias. In hyperkalemia, weakness can advance to flaccid paralysis, followed by irritability, disorientation, hyperreflexia, paresthesia or anesthesia, oliguria, anorexia, nausea, diarrhea, abdominal cramps, tachycardia or bradycardia, and arrhythmias.
Rhabdomyolysis
Manifestations encompass muscular weakness or discomfort, a Fever, nausea, emesis, lethargy, and black urine. Acute renal failure, resulting from obstruction and damage to renal structures as the kidneys struggle to filter myoglobin from the bloodstream, is a prevalent consequence.
Rheumatoid arthritis
Rheumatoid arthritis may present with symmetrical muscle weakening alongside heightened warmth, edema, and soreness in affected joints; discomfort; and stiffness, which limits mobility.
Epileptic condition
Transient generalized muscle weakness may manifest following a generalized tonic-clonic seizure; additional postictal symptoms encompass headache, myalgia, and significant weariness.
Spinal injury and pathology
Trauma can induce significant muscle weakening, resulting in flaccidity or spasticity and ultimately, paralysis. Infection, neoplasm, and cervical spondylosis or stenosis may also induce muscle weakness.
Cerebrovascular accident
A stroke may result in contralateral or bilateral weakness of the arms, legs, face, and tongue, contingent upon the location and severity of the injury, potentially advancing to hemiplegia and atrophy. Accompanying effects encompass dysarthria, aphasia, ataxia, apraxia, agnosia, ipsilateral paresthesia or sensory deficits, visual abnormalities, altered level of consciousness, forgetfulness, impaired judgment, personality alterations, bowel and bladder malfunction, headache, vomiting, and seizures.
Alternative Causes
Pharmaceuticals
Prolonged corticosteroid use, digoxin, and excessive dantrolene dosages can lead to generalized muscular weakness. Aminoglycoside drugs may exacerbate weakness in individuals with myasthenia gravis. Inertia. Immobilization by a cast, splint, or traction may induce muscular atrophy in the affected limb; extended bed rest or inactivity causes systemic muscle weakening.
Particular Considerations
Furnish assistive devices as required, and safeguard the patient from harm. In the presence of concurrent sensory loss, take precautions to prevent pressure ulcer development and thermal harm. In cases of chronic weakness, administer range of motion exercises or utilize splints for the limbs as required. Schedule therapy sessions to incorporate sufficient rest intervals, and dispense analgesics as required
EXAMINATION ADVICE Assessment of Muscular Strength Assess the patient's motor function comprehensively by evaluating strength in ten designated muscle groups. Request that he perform standard range-of-motion exercises while you provide resistance. Adjust the resistance level as needed to facilitate an accurate evaluation if the muscle group is deficient. If required, adjust the patient's position to alleviate gravitational resistance on the limbs, and conduct the test again.
Assess muscle strength using a scale from 0 to 5, where 0 indicates the absence of muscle contraction. 1 = Observable or tangible contraction without movement 2 = Complete muscle movement with the force of gravity removed 3 = Complete muscle movement against gravity but no movement against resistance 4 = Complete muscular movement against gravity; partial movement against resistance 5 = Complete muscle function against both gravity and resistance — normal-fortitude
Prepare the patient for blood testing, muscle biopsies, electromyography, nerve conduction studies, and X-rays or computed tomography scans. Patient ConsultationElucidate the significance of regular positional alterations and intervals of repose. Instruct the patient on the utilization of assistive equipment, as required.
Pediatric Insights
Muscular dystrophy, predominantly the Duchenne variant, is a significant contributor to muscle weakening in children.
Myopathy, also known Muscle weakness is identified through the observation and assessment of the strength of a specific muscle or muscle group. It may arise from a dysfunction in the cerebral hemispheres, brainstem, spinal cord, nerve roots, peripheral nerves, myoneural junctions, or within the muscle itself. Muscle weakness arises from specific neurological, musculoskeletal, metabolic, endocrine, and cardiovascular conditions; as a reaction to particular medications; and following extended immobility.
Medical History and Physical Assessment
Commence by identifying the site of the patient's muscular deficiency. Inquire whether he experiences challenges with particular motions, such as standing up from a chair. Inquire when he first observed the weakness; ask him if it exacerbates with physical activity or as the day advances. Inquire about associated symptoms, including musculoskeletal discomfort, altered sensory perception, and exhaustion. Gather a medical history, emphasizing chronic conditions such as hyperthyroidism; musculoskeletal or neurological issues, including recent injuries; a familial history of chronic muscle weakness, particularly in men; and substance use, including alcohol and drugs. Concentrate your physical assessment on assessing muscular strength. Assess all primary muscular groups bilaterally. . During testing, ensure that the patient's effort remains consistent; if it does not, consider the possibility of pain or other hesitance to exert effort. If the patient reports pain, alleviate or cease testing and have him attempt the exercises once more. Note that the patient's dominant arm, hand, and leg have greater strength than their nondominant equivalents. In addition to assessing individual muscle strength, evaluate the range of motion (ROM) at all principal joints (shoulder, elbow, wrist, hip, knee, and ankle). Additionally, assess sensory function in the affected regions and evaluate deep tendon reflexes (DTRs) bilaterally.
Etiological Factors
Amyotrophic lateral sclerosis (ALS). Amyotrophic lateral sclerosis (ALS) generally initiates with muscular weakness and atrophy in one hand, which swiftly disseminates to the corresponding arm and then to the other hand and arm. Ultimately, these consequences extend to the trunk, neck, tongue, larynx, pharynx, and legs; advancing respiratory muscle weakness results in respiratory insufficiency. Anemia. Muscle weakness and weariness of varying severity are intensified by exertion and momentarily alleviated by rest. Additional indications and symptoms encompass pallor, tachycardia, paresthesia, and a propensity for bleeding.
Intracranial neoplasm
The manifestations of muscle weakness differ based on the tumor's location and dimensions. Related symptoms encompass headache, vomiting, diplopia, reduced visual acuity, altered state of awareness (LOC), pupillary alterations, lower motor strength, hemiparesis, hemiplegia, decreased sensations, ataxia, seizures, and behavioral modifications.
Guillain-Barré syndrome
Rapidly advancing, symmetrical weakness and discomfort escalate from the feet to the arms and facial nerves, potentially culminating in complete motor paralysis and respiratory failure. Accompanying findings encompass sensory loss or paresthesia, muscle flaccidity, absence of deep tendon reflexes, and tachycardia. Bradycardia, variable hypertension and orthostatic hypotension, diaphoresis, incontinence of bowel and bladder, facial diplegia, dysphagia, dysarthria, and hypernasality.
Intervertebral disc herniation
Compression of nerve roots results in muscular weakening, disuse, and ultimately, atrophy. The principal symptom is intense lumbar pain, perhaps extending to the buttocks, legs, and foot, typically unilateral. Reflexes may be diminished, and sensory alterations may also manifest.
Hypercortisolism
Hypercortisolism can lead to muscular weakness and ultimately atrophy of the limbs. Cushingoid characteristics encompass buffalo hump, moon facies, truncal obesity, purple striae, atrophic skin, acne, hypertension, weariness, hyperpigmentation, easy bruising, impaired wound healing, and diaphoresis. The male patient may experience impotence; the female patient may display hirsutism and menstruation abnormalities.
Myasthenia gravis
The primary signs of myasthenia gravis are gradually growing skeletal muscular weakening and tiredness. Generally, weakness is slight upon awakening but intensifies over the day. Initial indicators comprise diminished eye closure, ptosis, and diplopia; expressionless, mask-like facial appearance; challenges in mastication and deglutition; nasal reflux of fluids accompanied by hypernasality; and a drooping jaw with a bobbing head. Involvement of the respiratory muscles may ultimately result in respiratory failure.
Osteoarthritis
Osteoarthritis is a chronic condition that results in gradual muscular disuse and weakness, ultimately leading to atrophy.
Parkinson's disease
In Parkinson's disease, a degenerative illness, muscle weakness is present alongside rigidity. Associated symptoms comprise a unilateral pill-rolling tremor, propulsive gait, dysarthria, bradykinesia, drooling, dysphagia, masklike facies, and a high-pitched, monotonous voice. Trauma to peripheral nerves. Extended pressure on or damage to a peripheral nerve results in muscular weakening and atrophy. Additional findings encompass paresthesia or sensory deficits, discomfort, and the absence of reflexes innervated by the affected nerve.
Potassium dysregulation
Hypokalemia may result in transient generalized muscle weakness, potentially accompanied by nausea, vomiting, diarrhea, impaired cognition, leg cramps, reduced reflexes, malaise, polyuria, dizziness, hypotension, and arrhythmias. In hyperkalemia, weakness can advance to flaccid paralysis, followed by irritability, disorientation, hyperreflexia, paresthesia or anesthesia, oliguria, anorexia, nausea, diarrhea, abdominal cramps, tachycardia or bradycardia, and arrhythmias.
Rhabdomyolysis
Manifestations encompass muscular weakness or discomfort, a Fever, nausea, emesis, lethargy, and black urine. Acute renal failure, resulting from obstruction and damage to renal structures as the kidneys struggle to filter myoglobin from the bloodstream, is a prevalent consequence.
Rheumatoid arthritis
Rheumatoid arthritis may present with symmetrical muscle weakening alongside heightened warmth, edema, and soreness in affected joints; discomfort; and stiffness, which limits mobility.
Epileptic condition
Transient generalized muscle weakness may manifest following a generalized tonic-clonic seizure; additional postictal symptoms encompass headache, myalgia, and significant weariness.
Spinal injury and pathology
Trauma can induce significant muscle weakening, resulting in flaccidity or spasticity and ultimately, paralysis. Infection, neoplasm, and cervical spondylosis or stenosis may also induce muscle weakness.
Cerebrovascular accident
A stroke may result in contralateral or bilateral weakness of the arms, legs, face, and tongue, contingent upon the location and severity of the injury, potentially advancing to hemiplegia and atrophy. Accompanying effects encompass dysarthria, aphasia, ataxia, apraxia, agnosia, ipsilateral paresthesia or sensory deficits, visual abnormalities, altered level of consciousness, forgetfulness, impaired judgment, personality alterations, bowel and bladder malfunction, headache, vomiting, and seizures.
Alternative Causes
Pharmaceuticals
Prolonged corticosteroid use, digoxin, and excessive dantrolene dosages can lead to generalized muscular weakness. Aminoglycoside drugs may exacerbate weakness in individuals with myasthenia gravis. Inertia. Immobilization by a cast, splint, or traction may induce muscular atrophy in the affected limb; extended bed rest or inactivity causes systemic muscle weakening.
Particular Considerations
Furnish assistive devices as required, and safeguard the patient from harm. In the presence of concurrent sensory loss, take precautions to prevent pressure ulcer development and thermal harm. In cases of chronic weakness, administer range of motion exercises or utilize splints for the limbs as required. Schedule therapy sessions to incorporate sufficient rest intervals, and dispense analgesics as required
EXAMINATION ADVICE Assessment of Muscular Strength Assess the patient's motor function comprehensively by evaluating strength in ten designated muscle groups. Request that he perform standard range-of-motion exercises while you provide resistance. Adjust the resistance level as needed to facilitate an accurate evaluation if the muscle group is deficient. If required, adjust the patient's position to alleviate gravitational resistance on the limbs, and conduct the test again.
Assess muscle strength using a scale from 0 to 5, where 0 indicates the absence of muscle contraction. 1 = Observable or tangible contraction without movement 2 = Complete muscle movement with the force of gravity removed 3 = Complete muscle movement against gravity but no movement against resistance 4 = Complete muscular movement against gravity; partial movement against resistance 5 = Complete muscle function against both gravity and resistance — normal-fortitude
Prepare the patient for blood testing, muscle biopsies, electromyography, nerve conduction studies, and X-rays or computed tomography scans. Patient ConsultationElucidate the significance of regular positional alterations and intervals of repose. Instruct the patient on the utilization of assistive equipment, as required.
Pediatric Insights
Muscular dystrophy, predominantly the Duchenne variant, is a significant contributor to muscle weakening in children.
- Published on
Symptoms and Signs – Differential Diagnosis of Muscle Spasticity
Spasticity is characterized by elevated muscular tone, resulting in augmented resistance to stretching and intensified reflexes. It is often identified by assessing a muscle's reaction to passive movement; a spastic muscle exhibits increased resistance during rapid passive movement. Spasticity, typically resulting from an upper motor neuron lesion, commonly manifests in the muscles of the arms and legs. Prolonged spasticity leads to muscular fibrosis and contractures.
Medical History and Physical Assessment
Upon identifying spasticity, inquire with the patient on its onset, duration, and progression. What events, if any, trigger its onset? Has he undergone additional muscular alterations or associated symptoms? Does his medical history indicate any occurrence of trauma or the presence of degenerative or vascular disease? Obtain the patient's vital signs and do a comprehensive neurological assessment. Assess reflexes and examine motor and sensory capabilities in all extremities. Assess muscles for atrophy and contractures. The Development of Spasticity Motor activity is regulated by pyramidal and extrapyramidal circuits that originate in the motor cortex, basal ganglia, brainstem, and spinal cord. Nerve fibers from different pathways converge and synapse at the anterior horn of the spinal cord. They together regulate segmental muscle tone by adjusting the stretch reflex arc. This arc is presented in a simplified manner.
A negative feedback loop wherein muscular stretch (stimulation) induces reflexive contraction (inhibition), thereby preserving muscle length and tone. Injury to specific pathways leads to diminished inhibition and disruption of the stretch reflex arc. Unrestrained muscle stretching induces excessive, unregulated muscle activation, highlighting the reflex arc and ultimately leading to spasticity. During your examination, note that generalized stiffness and trismus in a patient with a recent skin puncture or laceration suggest tetanus. Should you suspect this uncommon disorder, observe for indications of respiratory distress. Administer ventilatory assistance as needed and continuously observe the patient.
Etiological Factors
Amyotrophic lateral sclerosis (ALS)
Amyotrophic lateral sclerosis (ALS) typically results in stiffness, spasms, pronounced fasciculations, hyperactive deep tendon reflexes (DTRs), and a positive Babinski sign. Initial manifestations encompass gradual muscular weakness and flaccidity, generally commencing in the hands and arms. Ultimately disseminates throughout the trunk, neck, larynx, pharynx, and legs; advancing respiratory muscle weakness results in respiratory insufficiency. Additional results encompass dysphagia, dysarthria, sialorrhea, and sadness.
Epidural hematoma
Bilateral limb spasticity is a late and foreboding indicator of epidural hemorrhage. Additional findings encompass a transient loss of consciousness post-head trauma, succeeded by a lucid phase and thereafter a fast decline in the degree of consciousness (LOC). The patient may have unilateral hemiparesis or hemiplegia, convulsions, fixed dilated pupils, high fever, reduced and bounding pulse, widening pulse pressure, raised blood pressure, abnormal breathing pattern, and decerebrate posture. A positive Babinski sign may be induced.
Multiple sclerosis
Muscle spasticity or rigidity may manifest in individuals with multiple sclerosis. Additional symptoms may encompass limb weakness and sensory loss, unsteady gait, visual problems, and vertigo.
Spinal cord damage
Spasticity frequently arises from cervical and upper thoracic spinal cord injuries, particularly due to incomplete lesions. Spastic paralysis in the affected limbs ensues after initial flaccid paralysis; generally, spasticity and muscular atrophy intensify for approximately 1¼ to 2 years post-injury before gradually reverting to flaccidity. Signs and symptoms associated with the severity of injury may encompass respiratory insufficiency or paralysis, sensory deficits, bowel and bladder dysfunction, hyperactive deep tendon reflexes, a positive Babinski's sign, sexual dysfunction, priapism, hypotension, anhidrosis, and bradycardia.
Cerebrovascular accident
Spastic paralysis may manifest on the affected side subsequent to the acute phase of a stroke. Associated findings differ based on the location and severity of vascular injury and may encompass dysarthria, aphasia, ataxia, apraxia, agnosia, ipsilateral paresthesia or sensory deficits, visual disturbances, altered level of consciousness, amnesia, impaired judgment, personality alterations, emotional lability, bowel and bladder dysfunction, headache, vomiting, and seizures.
Tetanus
Tetanus is an uncommon, fatal illness characterized by variable levels of spasticity. In generalized tetanus, the predominant variant, initial signs and symptoms encompass severe stiffness of the jaw and neck, trismus, headache, irritability, restlessness, low-grade fever accompanied by chills, tachycardia, diaphoresis, and hyperactive deep tendon reflexes. With the advancement of the condition, painful involuntary spasms may disseminate, resulting in boardlike abdominal stiffness, opisthotonos, and a distinctive grotesque grin referred to as risus sardonicus. Reflex spasms can manifest in any muscle group with minimal provocation. Involvement of glottal, pharyngeal, or respiratory muscles can result in fatality due to suffocation or cardiac arrest.
Particular Considerations
Prepare the patient for diagnostic evaluations, which may encompass electromyography, muscle biopsy, or intracranial or spinal magnetic resonance imaging or computed tomography. Administer analgesics and an antispasmodic agent. Passive range-of-motion exercises, splinting, traction, and heat treatment may alleviate spasms and avert contractures. Foster a tranquil, serene atmosphere to alleviate spasms and avert recurrence, while promoting bed rest. In instances of persistent, unmanageable spasticity, such as spastic paralysis, nerve blocks or surgical transection may be required for enduring relief
Patient Consultation Instruct the patient on the utilization of assistive equipment as necessary and explore strategies to preserve autonomy.
Pediatric Guidelines In pediatric patients, muscular stiffness may indicate cerebral palsy.
Spasticity is characterized by elevated muscular tone, resulting in augmented resistance to stretching and intensified reflexes. It is often identified by assessing a muscle's reaction to passive movement; a spastic muscle exhibits increased resistance during rapid passive movement. Spasticity, typically resulting from an upper motor neuron lesion, commonly manifests in the muscles of the arms and legs. Prolonged spasticity leads to muscular fibrosis and contractures.
Medical History and Physical Assessment
Upon identifying spasticity, inquire with the patient on its onset, duration, and progression. What events, if any, trigger its onset? Has he undergone additional muscular alterations or associated symptoms? Does his medical history indicate any occurrence of trauma or the presence of degenerative or vascular disease? Obtain the patient's vital signs and do a comprehensive neurological assessment. Assess reflexes and examine motor and sensory capabilities in all extremities. Assess muscles for atrophy and contractures. The Development of Spasticity Motor activity is regulated by pyramidal and extrapyramidal circuits that originate in the motor cortex, basal ganglia, brainstem, and spinal cord. Nerve fibers from different pathways converge and synapse at the anterior horn of the spinal cord. They together regulate segmental muscle tone by adjusting the stretch reflex arc. This arc is presented in a simplified manner.
A negative feedback loop wherein muscular stretch (stimulation) induces reflexive contraction (inhibition), thereby preserving muscle length and tone. Injury to specific pathways leads to diminished inhibition and disruption of the stretch reflex arc. Unrestrained muscle stretching induces excessive, unregulated muscle activation, highlighting the reflex arc and ultimately leading to spasticity. During your examination, note that generalized stiffness and trismus in a patient with a recent skin puncture or laceration suggest tetanus. Should you suspect this uncommon disorder, observe for indications of respiratory distress. Administer ventilatory assistance as needed and continuously observe the patient.
Etiological Factors
Amyotrophic lateral sclerosis (ALS)
Amyotrophic lateral sclerosis (ALS) typically results in stiffness, spasms, pronounced fasciculations, hyperactive deep tendon reflexes (DTRs), and a positive Babinski sign. Initial manifestations encompass gradual muscular weakness and flaccidity, generally commencing in the hands and arms. Ultimately disseminates throughout the trunk, neck, larynx, pharynx, and legs; advancing respiratory muscle weakness results in respiratory insufficiency. Additional results encompass dysphagia, dysarthria, sialorrhea, and sadness.
Epidural hematoma
Bilateral limb spasticity is a late and foreboding indicator of epidural hemorrhage. Additional findings encompass a transient loss of consciousness post-head trauma, succeeded by a lucid phase and thereafter a fast decline in the degree of consciousness (LOC). The patient may have unilateral hemiparesis or hemiplegia, convulsions, fixed dilated pupils, high fever, reduced and bounding pulse, widening pulse pressure, raised blood pressure, abnormal breathing pattern, and decerebrate posture. A positive Babinski sign may be induced.
Multiple sclerosis
Muscle spasticity or rigidity may manifest in individuals with multiple sclerosis. Additional symptoms may encompass limb weakness and sensory loss, unsteady gait, visual problems, and vertigo.
Spinal cord damage
Spasticity frequently arises from cervical and upper thoracic spinal cord injuries, particularly due to incomplete lesions. Spastic paralysis in the affected limbs ensues after initial flaccid paralysis; generally, spasticity and muscular atrophy intensify for approximately 1¼ to 2 years post-injury before gradually reverting to flaccidity. Signs and symptoms associated with the severity of injury may encompass respiratory insufficiency or paralysis, sensory deficits, bowel and bladder dysfunction, hyperactive deep tendon reflexes, a positive Babinski's sign, sexual dysfunction, priapism, hypotension, anhidrosis, and bradycardia.
Cerebrovascular accident
Spastic paralysis may manifest on the affected side subsequent to the acute phase of a stroke. Associated findings differ based on the location and severity of vascular injury and may encompass dysarthria, aphasia, ataxia, apraxia, agnosia, ipsilateral paresthesia or sensory deficits, visual disturbances, altered level of consciousness, amnesia, impaired judgment, personality alterations, emotional lability, bowel and bladder dysfunction, headache, vomiting, and seizures.
Tetanus
Tetanus is an uncommon, fatal illness characterized by variable levels of spasticity. In generalized tetanus, the predominant variant, initial signs and symptoms encompass severe stiffness of the jaw and neck, trismus, headache, irritability, restlessness, low-grade fever accompanied by chills, tachycardia, diaphoresis, and hyperactive deep tendon reflexes. With the advancement of the condition, painful involuntary spasms may disseminate, resulting in boardlike abdominal stiffness, opisthotonos, and a distinctive grotesque grin referred to as risus sardonicus. Reflex spasms can manifest in any muscle group with minimal provocation. Involvement of glottal, pharyngeal, or respiratory muscles can result in fatality due to suffocation or cardiac arrest.
Particular Considerations
Prepare the patient for diagnostic evaluations, which may encompass electromyography, muscle biopsy, or intracranial or spinal magnetic resonance imaging or computed tomography. Administer analgesics and an antispasmodic agent. Passive range-of-motion exercises, splinting, traction, and heat treatment may alleviate spasms and avert contractures. Foster a tranquil, serene atmosphere to alleviate spasms and avert recurrence, while promoting bed rest. In instances of persistent, unmanageable spasticity, such as spastic paralysis, nerve blocks or surgical transection may be required for enduring relief
Patient Consultation Instruct the patient on the utilization of assistive equipment as necessary and explore strategies to preserve autonomy.
Pediatric Guidelines In pediatric patients, muscular stiffness may indicate cerebral palsy.
- Published on
Symptoms and Signs -Differential Diagnosis of Muscle Flaccidity [Muscle Hypotonicity]
Flaccid muscles exhibit significant weakness and softness, characterized by diminished resistance to movement, enhanced mobility, and an excessive range of motion (ROM). Flaccidity, resulting from disturbed muscular innervation, may be confined to a specific limb or muscle group or may be generalized throughout the whole. The onset may be abrupt, as seen in trauma, or persistent, as observed in neurological disease.
URGENT INTERVENTIONS
Ensure stabilization of the cervical spine if the patient's muscle flaccidity is attributable to trauma. Rapidly assess his breathing condition. If you
Observe signs and symptoms of respiratory insufficiency, including dyspnea, shallow respirations, nasal flaring, cyanosis, and reduced oxygen saturation; give oxygen via nasal cannula or mask. Intubation and mechanical ventilation may be required.
Medical History and Physical Assessment
In the absence of patient discomfort, inquire about the start, duration of muscular flaccidity, and any triggering circumstances. Inquire about concomitant symptoms, including weakness, alterations in muscle function, and sensory deficits or paresthesia.
Assess the impacted muscles for atrophy, signifying a persistent issue. Assess muscle strength and evaluate deep tendon reflexes (DTRs) in all extremities.
Etiological Factors in Medicine
Amyotrophic lateral sclerosis (ALS)
Progressive muscular weakening and paralysis are associated with widespread flaccidity. Generally, these effects initiate in one hand, propagate to the arm, and subsequently manifest in the opposite hand and arm. Ultimately, they disseminate throughout the trunk, neck, tongue, larynx, pharynx, and limbs; advancing respiratory muscle weakness results in respiratory insufficiency. Additional observations encompass muscle cramps, coarse fasciculations, hyperactive deep tendon reflexes, mild leg muscle spasticity, dysphagia, dysarthria, excessive salivation, and sadness.
Cerebral lesions
Lesions in the frontal and parietal lobes can result in contralateral flaccidity, weakness, or paralysis, which may progress to spasticity and potentially lead to contractures. Additional features encompass hyperactive deep tendon reflexes, a positive Babinski sign, loss of proprioception, stereognosis, graphesthesia, anesthesia, and thermoanesthesia.
Guillain-Barré syndrome
Guillain-Barré syndrome induces muscular hypotonia. The progression is generally symmetrical and ascends from the feet to the arms and facial nerves within 24 to 72 hours of commencement. Related findings encompass sensory loss or paresthesia, absent deep tendon reflexes, tachycardia (or, less frequently, bradycardia), variable hypertension and orthostatic hypotension, diaphoresis, incontinence, dysphagia, dysarthria, hypernasality, and facial diplegia. Weakness may advance to complete motor paralysis and respiratory collapse.
Huntington's disease
In addition to flaccidity, significant mental status alterations, culminating in dementia, and choreiform motions are primary concerns.
Indications of a condition
Additional symptoms encompass poor balance, reluctant or explosive speaking, dysphagia, decreased respiration, and incontinence.
Myopathy. Muscle weakness and flaccidity characterize myopathies and muscular dystrophies.
Trauma to peripheral nerves
Flaccidity, paralysis, and the absence of feeling and reflexes in the affected region may manifest.
Peripheral neuropathy
Flaccidity typically manifests in the legs due to prolonged increasing muscular weakening and paralysis. It may also induce mild to intense searing pain, lustrous red skin, anhidrosis, and a diminished sense of vibration. Paresthesia, hyperesthesia, or anesthesia may impact the hands and feet. Deep tendon reflexes may be diminished or missing.
Epileptic condition
Transient episodes of syncope and generalized flaccidity frequently occur subsequent to a generalized tonic-clonic seizure.
Spinal cord damage. Spinal shock may lead to immediate muscular flaccidity or spasticity underneath the lesion site. Signs and symptoms associated with the damage may manifest below the injury site and can include paralysis, absent deep tendon reflexes, analgesia, thermoanesthesia, loss of proprioception, and diminished sensations of vibration, touch, and pressure, as well as unilateral anhidrosis. Hypotension, gastrointestinal and urinary dysfunction, as well as impotence or priapism, may also manifest. Injury in the C1 to C5 area may result in respiratory paralysis and bradycardia.
Particular Considerations
Administer consistent, methodical, passive range of motion exercises to maintain joint mobility and enhance circulation. Reposition a patient exhibiting widespread flaccidity bi-hourly to avert skin breakdown. Cushion bony prominences and other pressure points, and mitigate thermal harm by personally checking the bath water prior to the patient's bathing. Address isolated flaccidity by immobilizing the affected limb using a sling or splint. Enhance patient safety and mitigate fall risk by implementing assistive devices and instructing on their appropriate utilization. Seek the expertise of a physician and an occupational therapist to develop a tailored therapeutic plan that promotes autonomy.
Prepare the patient for diagnostic evaluations, including cranial and spinal X-rays, computed tomography scans, and electromyography.
Patient Consultation
Instruct the patient on the utilization of assistive equipment and examine the planned workout routine with him.
Pediatric Guidelines
Pediatric etiologies of muscle flaccidity encompass myelomeningocele, Lowe syndrome, Werdnig-Hoffmann disease, and muscular dystrophy. A young child exhibiting overall flaccidity may assume a froglike posture, characterized by abducted hips and knees.
Flaccid muscles exhibit significant weakness and softness, characterized by diminished resistance to movement, enhanced mobility, and an excessive range of motion (ROM). Flaccidity, resulting from disturbed muscular innervation, may be confined to a specific limb or muscle group or may be generalized throughout the whole. The onset may be abrupt, as seen in trauma, or persistent, as observed in neurological disease.
URGENT INTERVENTIONS
Ensure stabilization of the cervical spine if the patient's muscle flaccidity is attributable to trauma. Rapidly assess his breathing condition. If you
Observe signs and symptoms of respiratory insufficiency, including dyspnea, shallow respirations, nasal flaring, cyanosis, and reduced oxygen saturation; give oxygen via nasal cannula or mask. Intubation and mechanical ventilation may be required.
Medical History and Physical Assessment
In the absence of patient discomfort, inquire about the start, duration of muscular flaccidity, and any triggering circumstances. Inquire about concomitant symptoms, including weakness, alterations in muscle function, and sensory deficits or paresthesia.
Assess the impacted muscles for atrophy, signifying a persistent issue. Assess muscle strength and evaluate deep tendon reflexes (DTRs) in all extremities.
Etiological Factors in Medicine
Amyotrophic lateral sclerosis (ALS)
Progressive muscular weakening and paralysis are associated with widespread flaccidity. Generally, these effects initiate in one hand, propagate to the arm, and subsequently manifest in the opposite hand and arm. Ultimately, they disseminate throughout the trunk, neck, tongue, larynx, pharynx, and limbs; advancing respiratory muscle weakness results in respiratory insufficiency. Additional observations encompass muscle cramps, coarse fasciculations, hyperactive deep tendon reflexes, mild leg muscle spasticity, dysphagia, dysarthria, excessive salivation, and sadness.
Cerebral lesions
Lesions in the frontal and parietal lobes can result in contralateral flaccidity, weakness, or paralysis, which may progress to spasticity and potentially lead to contractures. Additional features encompass hyperactive deep tendon reflexes, a positive Babinski sign, loss of proprioception, stereognosis, graphesthesia, anesthesia, and thermoanesthesia.
Guillain-Barré syndrome
Guillain-Barré syndrome induces muscular hypotonia. The progression is generally symmetrical and ascends from the feet to the arms and facial nerves within 24 to 72 hours of commencement. Related findings encompass sensory loss or paresthesia, absent deep tendon reflexes, tachycardia (or, less frequently, bradycardia), variable hypertension and orthostatic hypotension, diaphoresis, incontinence, dysphagia, dysarthria, hypernasality, and facial diplegia. Weakness may advance to complete motor paralysis and respiratory collapse.
Huntington's disease
In addition to flaccidity, significant mental status alterations, culminating in dementia, and choreiform motions are primary concerns.
Indications of a condition
Additional symptoms encompass poor balance, reluctant or explosive speaking, dysphagia, decreased respiration, and incontinence.
Myopathy. Muscle weakness and flaccidity characterize myopathies and muscular dystrophies.
Trauma to peripheral nerves
Flaccidity, paralysis, and the absence of feeling and reflexes in the affected region may manifest.
Peripheral neuropathy
Flaccidity typically manifests in the legs due to prolonged increasing muscular weakening and paralysis. It may also induce mild to intense searing pain, lustrous red skin, anhidrosis, and a diminished sense of vibration. Paresthesia, hyperesthesia, or anesthesia may impact the hands and feet. Deep tendon reflexes may be diminished or missing.
Epileptic condition
Transient episodes of syncope and generalized flaccidity frequently occur subsequent to a generalized tonic-clonic seizure.
Spinal cord damage. Spinal shock may lead to immediate muscular flaccidity or spasticity underneath the lesion site. Signs and symptoms associated with the damage may manifest below the injury site and can include paralysis, absent deep tendon reflexes, analgesia, thermoanesthesia, loss of proprioception, and diminished sensations of vibration, touch, and pressure, as well as unilateral anhidrosis. Hypotension, gastrointestinal and urinary dysfunction, as well as impotence or priapism, may also manifest. Injury in the C1 to C5 area may result in respiratory paralysis and bradycardia.
Particular Considerations
Administer consistent, methodical, passive range of motion exercises to maintain joint mobility and enhance circulation. Reposition a patient exhibiting widespread flaccidity bi-hourly to avert skin breakdown. Cushion bony prominences and other pressure points, and mitigate thermal harm by personally checking the bath water prior to the patient's bathing. Address isolated flaccidity by immobilizing the affected limb using a sling or splint. Enhance patient safety and mitigate fall risk by implementing assistive devices and instructing on their appropriate utilization. Seek the expertise of a physician and an occupational therapist to develop a tailored therapeutic plan that promotes autonomy.
Prepare the patient for diagnostic evaluations, including cranial and spinal X-rays, computed tomography scans, and electromyography.
Patient Consultation
Instruct the patient on the utilization of assistive equipment and examine the planned workout routine with him.
Pediatric Guidelines
Pediatric etiologies of muscle flaccidity encompass myelomeningocele, Lowe syndrome, Werdnig-Hoffmann disease, and muscular dystrophy. A young child exhibiting overall flaccidity may assume a froglike posture, characterized by abducted hips and knees.
- Published on
Symptoms and Signs -Differential Diagnosis of Muscle Spasms
Muscle spasms are intense, painful contractions. They may manifest in nearly any muscle, though they are predominantly found in the calf and foot. Muscle spasms generally arise from basic muscle tiredness, post-exercise, and during gestation. Nonetheless, they may also arise from electrolyte imbalances, neuromuscular diseases, or as a consequence of specific medications. They are generally triggered by movement, particularly abrupt or jerking motions, and can often be alleviated with gradual stretching.
URGENT INTERVENTIONS
Should the patient report frequent or persistent muscle spasms, together with paresthesia in the hands and feet, promptly assess for Chvostek’s and Trousseau’s symptoms. In the presence of these indications, consider hypocalcemia. Assess respiratory function, monitoring for laryngospasm; administer supplemental oxygen as required, and prepare for intubation and mechanical ventilation. Obtain blood samples for calcium and electrolyte assessment, as well as arterial blood gas analysis, and establish an intravenous line for calcium supplementation. Assess the patient's heart condition and be ready to initiate resuscitation if required.
Medical History and Physical Assessment
Inquire about the onset of spasms if the patient is not in distress. Is there a certain action that triggers them? What was their duration? What was the extent of their pain? Did any factors exacerbate or alleviate the pain? Inquire for further symptoms, including weakness, sensory impairment, or paresthesia.
Assess muscular strength and tone. Subsequently, evaluate all primary muscle groups and record if motions induce spasms. Assess the existence and quality of all peripheral pulses, and inspect the extremities for alterations in color and temperature. Evaluate the capillary refill time (normal is under 3 seconds) and examine for edema, particularly in the affected region. Monitor for indicators of dehydration, including dry mucous membranes. Acquire a comprehensive pharmacological and dietary history. Inquire whether the patient has experienced recent episodes of vomiting or diarrhea. Ultimately, assess reflexes and sensory function in all extremities.
Etiological Factors
Amyotrophic lateral sclerosis (ALS)
In ALS, muscle spasms may occur alongside progressive muscle weakening and atrophy, which usually initiate in one hand, subsequently affecting the arm, and then extending to the other hand and arm. Ultimately, muscular weakness and atrophy impact the trunk, neck, tongue, larynx, pharynx, and legs; advancing respiratory muscle weakness results in respiratory insufficiency. Additional observations encompass muscle flaccidity evolving into spasticity, pronounced fasciculations, hyperactive deep tendon reflexes (DTRs), dysphagia, speech impairment, excessive salivation, and depression.
Arterial occlusion disease
Arterial occlusion generally results in spasms and intermittent claudication in the leg, accompanied by lingering pain. Related signs are typically confined to the legs and feet, encompassing diminished peripheral pulses, pallor or cyanosis, reduced sensibility, alopecia, xerosis or desquamation, edema, and ulcerations.
Cholera
Muscle spasms, significant fluid and electrolyte depletion, intense thirst, weakness, diminished skin turgor, oliguria, tachycardia, and hypotension accompany sudden watery diarrhea and vomiting.
Desiccation
Depletion of sodium may result in cramps in the limbs and abdomen. Additional observations comprise mild fever, diminished skin turgor, dry mucous membranes, tachycardia, orthostatic hypotension, muscular twitching, seizures, nausea, vomiting, and oliguria.
Hypocalcemia
The hallmark characteristic is tetany – a condition involving muscle.Muscle cramps and twitching, carpopedal and facial spasms, along with convulsions, potentially accompanied by stridor. Chvostek's and Trousseau's indications may be observed. Associated observations encompass lip, finger, and toe paresthesia; choreiform motions; hyperactive deep tendon reflexes; weariness; palpitations; and cardiac arrhythmias.
Muscle injury
Excessive muscular strain may induce mild to severe spasms. The affected region may exhibit pain, swelling, erythema, or increased warmth.
Respiratory alkalosis
The sudden emergence of muscle spasms may be associated with twitching and weakness, carpopedal spasms, circumoral and peripheral paresthesia, vertigo, syncope, pallor, and severe anxiety. Severe alkalosis may precipitate cardiac arrhythmias.
Spinal damage or pathology
Muscle spasms may arise from spinal injuries, including cervical extension injuries or spinous process fractures, or from spinal diseases such as infections.
Alternative Causes
Pharmaceuticals. Drugs commonly associated with spasms include diuretics, corticosteroids, and estrogens.
Particular Considerations
To alleviate the patient's spasms, gradually stretch the affected muscle in the direction opposing the contraction, contingent upon the underlying reason. Administer a little analgesic if required.
Diagnostic evaluations may encompass serum calcium, salt, and carbon dioxide concentrations, thyroid function assessments, as well as blood flow examinations or arteriography.
Patient Consultation
Examine analgesic strategies. Elucidate immobilization and the technique for wrapping the wounded region. Instruct the patient on the utilization of assistive equipment, as required.
Pediatric Guidelines
Muscle spasms infrequently manifest in youngsters. Nonetheless, their presence may signify hypoparathyroidism, osteomalacia, rickets, or, infrequently, congenital torticollis.
Muscle spasms are intense, painful contractions. They may manifest in nearly any muscle, though they are predominantly found in the calf and foot. Muscle spasms generally arise from basic muscle tiredness, post-exercise, and during gestation. Nonetheless, they may also arise from electrolyte imbalances, neuromuscular diseases, or as a consequence of specific medications. They are generally triggered by movement, particularly abrupt or jerking motions, and can often be alleviated with gradual stretching.
URGENT INTERVENTIONS
Should the patient report frequent or persistent muscle spasms, together with paresthesia in the hands and feet, promptly assess for Chvostek’s and Trousseau’s symptoms. In the presence of these indications, consider hypocalcemia. Assess respiratory function, monitoring for laryngospasm; administer supplemental oxygen as required, and prepare for intubation and mechanical ventilation. Obtain blood samples for calcium and electrolyte assessment, as well as arterial blood gas analysis, and establish an intravenous line for calcium supplementation. Assess the patient's heart condition and be ready to initiate resuscitation if required.
Medical History and Physical Assessment
Inquire about the onset of spasms if the patient is not in distress. Is there a certain action that triggers them? What was their duration? What was the extent of their pain? Did any factors exacerbate or alleviate the pain? Inquire for further symptoms, including weakness, sensory impairment, or paresthesia.
Assess muscular strength and tone. Subsequently, evaluate all primary muscle groups and record if motions induce spasms. Assess the existence and quality of all peripheral pulses, and inspect the extremities for alterations in color and temperature. Evaluate the capillary refill time (normal is under 3 seconds) and examine for edema, particularly in the affected region. Monitor for indicators of dehydration, including dry mucous membranes. Acquire a comprehensive pharmacological and dietary history. Inquire whether the patient has experienced recent episodes of vomiting or diarrhea. Ultimately, assess reflexes and sensory function in all extremities.
Etiological Factors
Amyotrophic lateral sclerosis (ALS)
In ALS, muscle spasms may occur alongside progressive muscle weakening and atrophy, which usually initiate in one hand, subsequently affecting the arm, and then extending to the other hand and arm. Ultimately, muscular weakness and atrophy impact the trunk, neck, tongue, larynx, pharynx, and legs; advancing respiratory muscle weakness results in respiratory insufficiency. Additional observations encompass muscle flaccidity evolving into spasticity, pronounced fasciculations, hyperactive deep tendon reflexes (DTRs), dysphagia, speech impairment, excessive salivation, and depression.
Arterial occlusion disease
Arterial occlusion generally results in spasms and intermittent claudication in the leg, accompanied by lingering pain. Related signs are typically confined to the legs and feet, encompassing diminished peripheral pulses, pallor or cyanosis, reduced sensibility, alopecia, xerosis or desquamation, edema, and ulcerations.
Cholera
Muscle spasms, significant fluid and electrolyte depletion, intense thirst, weakness, diminished skin turgor, oliguria, tachycardia, and hypotension accompany sudden watery diarrhea and vomiting.
Desiccation
Depletion of sodium may result in cramps in the limbs and abdomen. Additional observations comprise mild fever, diminished skin turgor, dry mucous membranes, tachycardia, orthostatic hypotension, muscular twitching, seizures, nausea, vomiting, and oliguria.
Hypocalcemia
The hallmark characteristic is tetany – a condition involving muscle.Muscle cramps and twitching, carpopedal and facial spasms, along with convulsions, potentially accompanied by stridor. Chvostek's and Trousseau's indications may be observed. Associated observations encompass lip, finger, and toe paresthesia; choreiform motions; hyperactive deep tendon reflexes; weariness; palpitations; and cardiac arrhythmias.
Muscle injury
Excessive muscular strain may induce mild to severe spasms. The affected region may exhibit pain, swelling, erythema, or increased warmth.
Respiratory alkalosis
The sudden emergence of muscle spasms may be associated with twitching and weakness, carpopedal spasms, circumoral and peripheral paresthesia, vertigo, syncope, pallor, and severe anxiety. Severe alkalosis may precipitate cardiac arrhythmias.
Spinal damage or pathology
Muscle spasms may arise from spinal injuries, including cervical extension injuries or spinous process fractures, or from spinal diseases such as infections.
Alternative Causes
Pharmaceuticals. Drugs commonly associated with spasms include diuretics, corticosteroids, and estrogens.
Particular Considerations
To alleviate the patient's spasms, gradually stretch the affected muscle in the direction opposing the contraction, contingent upon the underlying reason. Administer a little analgesic if required.
Diagnostic evaluations may encompass serum calcium, salt, and carbon dioxide concentrations, thyroid function assessments, as well as blood flow examinations or arteriography.
Patient Consultation
Examine analgesic strategies. Elucidate immobilization and the technique for wrapping the wounded region. Instruct the patient on the utilization of assistive equipment, as required.
Pediatric Guidelines
Muscle spasms infrequently manifest in youngsters. Nonetheless, their presence may signify hypoparathyroidism, osteomalacia, rickets, or, infrequently, congenital torticollis.
- Published on
Filariasis
Filariasis is a parasitic tropical disease caused by thread-like nematode worms belonging to the subfamily Filarioidea, spread by vectors.
• Nine species of filarial worms utilize humans as definitive hosts, residing in lymphatics, skin, connective tissue, serous cavities, and blood vessels. • Adult worms can inhabit the host for more than 20 years.
EPIDEMIOLOGY • Bancroftian and Malayan filariasis – Endemic in 83 countries across tropical and subtropical regions of Asia, Africa, Central and South America, and Pacific Island states. Approximately 1.3 billion individuals globally are at risk of illness (1).
- 120 million individuals have already been infected (1).
Approximately 40 million individuals are afflicted with debilitating or disfiguring diseases (1).
• Loiasis
- Restricted to the rainforest region of western and central Africa. Humans constitute the sole identified reservoir. • Onchocerciasis (“river blindness”) - Approximately 18 million individuals are affected (1).
– Approximately 270,000 individuals are blind, and a further 500,000 are visually impaired. Second primary cause of global blindness behind trachoma (1).
- Illness observed in South America and Africa.
Dracunculiasis (Guinea worm) primarily manifests in a limited region encompassing some African nations and Yemen (1). • Dirofilariasis (Canine heartworm) – Symptomatic infection infrequent (1) – Global distribution Mansonelliasis is a disease prevalent in Africa, Central and South America, and the Caribbean.
FACTORS OF RISK
• Residing in or visiting endemic regions • Diminished socio-economic standing
Genetics
No genetic variables are implicated
GENERAL PREVENTION • Health education • Vector control strategies
• Sleep beneath a mosquito net • Apply insect repellent containing a minimum of 30% DEET (N,N-Diethyl-meta-toluamide) on exposed skin and clothing • Wear long-sleeved garments to avert insect bites • Administer diethylcarbamazine 300 mg/week orally as prophylaxis against Loiasis • Dracunculiasis – Consume clean, boiled water – Filter copepods from drinking water – Restrict individuals with Guinea worm ulcers from accessing drinking water sources
- Administer chemical treatments, such as Abate, to eliminate copepods in contaminated water sources. - Introduce fish species that consume copepods into affected water bodies.
PATHOPHYSIOLOGY • Bancroftian and Malayan Filariasis Adult worms induce hypertrophy and dilation of lymphatic channels, resulting in valve dysfunction and subsequent extensive permanent lymphedema.
“Elephantiasis.” • Loiasis – Larvae infiltrate through the bite of a red fly, subsequently molting and migrating beneath the skin, resulting in temporary migratory angioedema (“Calabar” swellings), discomfort, pruritus, and urticaria, which are localized hypersensitivity reactions.
• Onchocerciasis — Larvae are introduced through a blackfly bite, mature, and reproduce, yielding microfilariae around one year post-bite. Adult worms reside in nodules inside the dermis and deep fascia. Microfilariae traverse the dermis and may infiltrate the ocular region, resulting in inflammation that can lead to blindness, known as "river blindness," as well as skin nodules and onchodermatitis.
• Dracunculiasis – Larvae are consumed by contaminated drinking water containing infected copepods. Larvae are discharged. They infiltrate the intestine, develop within the abdominal cavity, and reproduce. Male specimens perish, while gravid females move to the lower extremities, where they generate a papule that ultimately ulcerates. The worm surfaces to discharge larvae upon contact with water. Worms that do not penetrate the skin perish and undergo calcification.
Dirofilariasis involves worms that elicit a mild granulomatous response in subcutaneous tissue or obstruct a pulmonary artery, resulting in a solitary, minor pulmonary infarct.
Mansonelliasis involves the release of antigenic material from dying worms, which triggers an inflammatory response that leads to the formation of localized abscesses and granulomas.
ETIOLOGY
• Lymphatic filariasis – Infection caused by Wuchereria bancrofti, Brugia malayi, and Brugia timori – Transmitted by mosquitoes of the Anopheles, Aedes, Culex, and Mansonia genera
• Loa loa is transmitted by red tabanid flies (Chrysops species). • Onchocerca volvulus is transmitted by blackflies (Simulium species).
Dracunculus medinensis is consumed through drinking water contaminated with infected microcrustaceans (copepods).
Dirofilaria species spread by Culex mosquitoes.
Mansonella streptocerca is transmitted by midges of the Culicoides genus.
Mansonella perstans and Mansonella ozzardi induce serous cavity filariasis.
FREQUENTLY CO-OCCURRING CONDITIONS
No frequently correlated situations
DIAGNOSTIC HISTORY • Bancroftian and Malayan filariasis – Acute manifestations including fever, lymphadenitis, lymphangitis, funiculitis, and epididymitis – Chronic manifestations including abscesses, hyperkeratosis, polyarthritis, hydroceles, lymphoedema, and elephantiasis – Bronchospasm
• Loiasis – Temporary edema, typically of the wrists and ankles, accompanied by pruritus, paresthesia, and urticaria – Worm migration within the ocular region • Onchocerciasis – Subcutaneous nodules, pruritus, rashes, lymphadenopathy, lymphatic obstruction, chronic dermatological conditions, ocular lesions • Dracunculiasis – Painful, inflamed cutaneous lesion harboring a worm and arthritis • Dirofilariasis – Thoracic pain, cough, and hemoptysis • Mansonelliasis
Localized edema, pruritus, pyrexia, cephalalgia, arthralgia, neurological symptoms, and hydroceles
Inquire on travel to endemic regions.
PHYSICAL EXAMINATION
• Bancroftian and Malayan filariasis – Lymphangitis and lymphadenitis – Femoral/inguinal lymphadenopathy – Enlarged epididymis and spermatic cord – Hydrocele, lower extremity lymphoedema – May induce monoarticular arthritis
• Loiasis – Mature worms may migrate beneath the conjunctiva or into the dermis.
Calabar swelling frequently occurs in the wrists and ankles; the edema may persist for only hours but might repeat over several years. • Onchocerciasis – Dermatological alterations range from papular eruptions to regions of hyper- or hypopigmentation.
– Patients may exhibit eczematoid dermatitis and dermal thickening.
– Nontender subcutaneous nodules. – Potential reduction in optical acuity. • Dracunculiasis – A white, filamentous adult worm manifests at the cutaneous surface.
Ulceration in distal extremities. • Dirofilariasis – Typically asymptomatic Mansonelliasis is characterized by angioedema, pruritus, papular rash, alterations in skin pigmentation, fever, headaches, arthralgia, lymphadenopathy, hepatomegaly, and neurological symptoms.
DIAGNOSTIC TESTS AND INTERPRETATION Laboratory
• Bancroftian and Malayan filariasis - Blood smears reveal the presence of filarial worms.
– Serological assays lack specificity in filariasis. – Eosinophilia is frequently absent.
– PCR-based assays for the DNA of W. bancrofti and B. malayi are accessible in research environments.
• Loiasis – Blood smears, skin snips, or skin biopsy
• Onchocerciasis – Microscopic examination of skin biopsies reveals the presence of worms – Dracunculiasis – Diagnosis is clinical.
• Dirofilariasis - Histological Examination
• Mansonelliasis – Blood smears reveal filarial worms.
Microscopic examination of the skin biopsy reveals the presence of worms. Eosinophilia is significant.
Imaging
• Bancroftian and Malayan filariasis — Adult worms may be observed in dilated lymphatics using ultrasound. • Onchocerciasis – Cutaneous and subcutaneous nodules identified with ultrasound and magnetic resonance imaging.
• Dracunculiasis – Standard radiography reveal calcified worms.
• Dirofilariasis – Larvae can become encapsulated within necrotic lung tissue, resulting in distinct pulmonary nodules that may be detectable on computed tomography images.
DIFFERENTIAL DIAGNOSIS
Bancroftian and Malayan filariasis include bacterial lymphangitis, thrombophlebitis, idiopathic hydrocele, congestive heart failure, cirrhosis, and nephrotic syndrome. • Loiasis
– Cutaneous larva migrans, dracunculiasis, gnathostomiasis, myiasis, onchocerciasis • Onchocerciasis – M. streptocerca, scabies, leprosy, eczema, glaucoma, loiasis • Dracunculiasis – Cutaneous larva migrans, loiasis, rat bite infection, gnathostomiasis, myiasis • Dirofilariasis – Asthma, allergies, lung cancer • Mansonelliasis – Loiasis, onchocerciasis
INITIAL THERAPEUTIC AGENT
• Bancroftian and Malayan filariasis — Wolbachia spp., a genus of Rickettsia, are essential for filarial growth. Administer Doxycycline 100 mg orally twice daily for a duration of 4 to 6 weeks to address Wolbachia. Four months subsequent to initiating treatment, a single dosage of albendazole 400 mg orally and ivermectin 150 mg/kg orally was administered.
• Loiasis - Administer a single dosage of diethylcarbamazine citrate (DEC) at 6 mg/kg orally.
• Onchocerciasis - Administer one dosage of ivermectin at 150 mcg/kg orally (ineffective against mature worms). Recur in six months.
– Administer prednisone at a dosage of 1 mg/kg/day orally one week prior to ivermectin if ocular involvement is present.
• Dracunculiasis – Gradual and meticulous removal of the protruding worm.
Metronidazole 250 mg administered orally three times daily may
Mitigate inflammatory response, hence aiding in the expulsion of worms. Mebendazole 400–800 mg each day for 6 days may eradicate the worm.
• M. perstans – Administer albendazole 400 mg orally twice daily for 10 days. • M. streptocerca and M. ozzardi – Administer a single dose of ivermectin at 200 mcg/kg. • Dirofilariasis – No effective pharmacological treatment available. Second Line
• Bancroftian and Malayan filariasis – DEC, as previously mentioned for M. streptocerca. DEC should not be administered in regions with endemic lymphatic filariasis and loiasis/onchocerciasis.
SUPPLEMENTARY THERAPY
Comprehensive Measures
The treatment primarily targets the microfilarial stage of the infection. Adult worms are seldom impacted by a single dose of medicine. Repetitive therapy is frequently required for a cure.
Concerns for Referral
• Specialists in infectious diseases • Ophthalmologist for ocular assessment in onchocerciasis
CHIRURGICAL INTERVENTIONS/ADDITIONAL PROCEDURES
• Nodulectomy of palpable nodules in onchocerciasis • Surgical excision of dirofilariasis from the lung IN-PATIENT CONSIDERATIONS
Preliminary Stabilization
Resuscitation in accordance with advanced life support protocols as necessary
Criteria for Admission
• Patients with septicemia resulting from open wounds • Overnight admission for nocturnal blood sample collection for diagnostic testing
IV Fluids • Administer fluid resuscitation using colloids, such as Gelofusine, in cases of septicemia.
• Maintenance fluids utilizing Ringer's lactate
Nursing
Patients with elephantiasis may require comprehensive nursing care for the affected body portion.
Release Criteria for the resolution of septicemia
CONTINUING CARE POST-TREATMENT RECOMMENDATIONS
Every 4 to 6 weeks for treatment evaluation and symptomatic management
Patient Surveillance
Routine ocular assessments
OUTLOOK
Disability and disfigurement are mitigated by accurate diagnosis and therapy.
COMPLICATIONS
Bancroftian filariasis - Elephantiasis; Septicemia resulting from bacterial infection of exposed sores.
• Onchocerciasis - Visual Impairment
Filariasis is a parasitic tropical disease caused by thread-like nematode worms belonging to the subfamily Filarioidea, spread by vectors.
• Nine species of filarial worms utilize humans as definitive hosts, residing in lymphatics, skin, connective tissue, serous cavities, and blood vessels. • Adult worms can inhabit the host for more than 20 years.
EPIDEMIOLOGY • Bancroftian and Malayan filariasis – Endemic in 83 countries across tropical and subtropical regions of Asia, Africa, Central and South America, and Pacific Island states. Approximately 1.3 billion individuals globally are at risk of illness (1).
- 120 million individuals have already been infected (1).
Approximately 40 million individuals are afflicted with debilitating or disfiguring diseases (1).
• Loiasis
- Restricted to the rainforest region of western and central Africa. Humans constitute the sole identified reservoir. • Onchocerciasis (“river blindness”) - Approximately 18 million individuals are affected (1).
– Approximately 270,000 individuals are blind, and a further 500,000 are visually impaired. Second primary cause of global blindness behind trachoma (1).
- Illness observed in South America and Africa.
Dracunculiasis (Guinea worm) primarily manifests in a limited region encompassing some African nations and Yemen (1). • Dirofilariasis (Canine heartworm) – Symptomatic infection infrequent (1) – Global distribution Mansonelliasis is a disease prevalent in Africa, Central and South America, and the Caribbean.
FACTORS OF RISK
• Residing in or visiting endemic regions • Diminished socio-economic standing
Genetics
No genetic variables are implicated
GENERAL PREVENTION • Health education • Vector control strategies
• Sleep beneath a mosquito net • Apply insect repellent containing a minimum of 30% DEET (N,N-Diethyl-meta-toluamide) on exposed skin and clothing • Wear long-sleeved garments to avert insect bites • Administer diethylcarbamazine 300 mg/week orally as prophylaxis against Loiasis • Dracunculiasis – Consume clean, boiled water – Filter copepods from drinking water – Restrict individuals with Guinea worm ulcers from accessing drinking water sources
- Administer chemical treatments, such as Abate, to eliminate copepods in contaminated water sources. - Introduce fish species that consume copepods into affected water bodies.
PATHOPHYSIOLOGY • Bancroftian and Malayan Filariasis Adult worms induce hypertrophy and dilation of lymphatic channels, resulting in valve dysfunction and subsequent extensive permanent lymphedema.
“Elephantiasis.” • Loiasis – Larvae infiltrate through the bite of a red fly, subsequently molting and migrating beneath the skin, resulting in temporary migratory angioedema (“Calabar” swellings), discomfort, pruritus, and urticaria, which are localized hypersensitivity reactions.
• Onchocerciasis — Larvae are introduced through a blackfly bite, mature, and reproduce, yielding microfilariae around one year post-bite. Adult worms reside in nodules inside the dermis and deep fascia. Microfilariae traverse the dermis and may infiltrate the ocular region, resulting in inflammation that can lead to blindness, known as "river blindness," as well as skin nodules and onchodermatitis.
• Dracunculiasis – Larvae are consumed by contaminated drinking water containing infected copepods. Larvae are discharged. They infiltrate the intestine, develop within the abdominal cavity, and reproduce. Male specimens perish, while gravid females move to the lower extremities, where they generate a papule that ultimately ulcerates. The worm surfaces to discharge larvae upon contact with water. Worms that do not penetrate the skin perish and undergo calcification.
Dirofilariasis involves worms that elicit a mild granulomatous response in subcutaneous tissue or obstruct a pulmonary artery, resulting in a solitary, minor pulmonary infarct.
Mansonelliasis involves the release of antigenic material from dying worms, which triggers an inflammatory response that leads to the formation of localized abscesses and granulomas.
ETIOLOGY
• Lymphatic filariasis – Infection caused by Wuchereria bancrofti, Brugia malayi, and Brugia timori – Transmitted by mosquitoes of the Anopheles, Aedes, Culex, and Mansonia genera
• Loa loa is transmitted by red tabanid flies (Chrysops species). • Onchocerca volvulus is transmitted by blackflies (Simulium species).
Dracunculus medinensis is consumed through drinking water contaminated with infected microcrustaceans (copepods).
Dirofilaria species spread by Culex mosquitoes.
Mansonella streptocerca is transmitted by midges of the Culicoides genus.
Mansonella perstans and Mansonella ozzardi induce serous cavity filariasis.
FREQUENTLY CO-OCCURRING CONDITIONS
No frequently correlated situations
DIAGNOSTIC HISTORY • Bancroftian and Malayan filariasis – Acute manifestations including fever, lymphadenitis, lymphangitis, funiculitis, and epididymitis – Chronic manifestations including abscesses, hyperkeratosis, polyarthritis, hydroceles, lymphoedema, and elephantiasis – Bronchospasm
• Loiasis – Temporary edema, typically of the wrists and ankles, accompanied by pruritus, paresthesia, and urticaria – Worm migration within the ocular region • Onchocerciasis – Subcutaneous nodules, pruritus, rashes, lymphadenopathy, lymphatic obstruction, chronic dermatological conditions, ocular lesions • Dracunculiasis – Painful, inflamed cutaneous lesion harboring a worm and arthritis • Dirofilariasis – Thoracic pain, cough, and hemoptysis • Mansonelliasis
Localized edema, pruritus, pyrexia, cephalalgia, arthralgia, neurological symptoms, and hydroceles
Inquire on travel to endemic regions.
PHYSICAL EXAMINATION
• Bancroftian and Malayan filariasis – Lymphangitis and lymphadenitis – Femoral/inguinal lymphadenopathy – Enlarged epididymis and spermatic cord – Hydrocele, lower extremity lymphoedema – May induce monoarticular arthritis
• Loiasis – Mature worms may migrate beneath the conjunctiva or into the dermis.
Calabar swelling frequently occurs in the wrists and ankles; the edema may persist for only hours but might repeat over several years. • Onchocerciasis – Dermatological alterations range from papular eruptions to regions of hyper- or hypopigmentation.
– Patients may exhibit eczematoid dermatitis and dermal thickening.
– Nontender subcutaneous nodules. – Potential reduction in optical acuity. • Dracunculiasis – A white, filamentous adult worm manifests at the cutaneous surface.
Ulceration in distal extremities. • Dirofilariasis – Typically asymptomatic Mansonelliasis is characterized by angioedema, pruritus, papular rash, alterations in skin pigmentation, fever, headaches, arthralgia, lymphadenopathy, hepatomegaly, and neurological symptoms.
DIAGNOSTIC TESTS AND INTERPRETATION Laboratory
• Bancroftian and Malayan filariasis - Blood smears reveal the presence of filarial worms.
– Serological assays lack specificity in filariasis. – Eosinophilia is frequently absent.
– PCR-based assays for the DNA of W. bancrofti and B. malayi are accessible in research environments.
• Loiasis – Blood smears, skin snips, or skin biopsy
• Onchocerciasis – Microscopic examination of skin biopsies reveals the presence of worms – Dracunculiasis – Diagnosis is clinical.
• Dirofilariasis - Histological Examination
• Mansonelliasis – Blood smears reveal filarial worms.
Microscopic examination of the skin biopsy reveals the presence of worms. Eosinophilia is significant.
Imaging
• Bancroftian and Malayan filariasis — Adult worms may be observed in dilated lymphatics using ultrasound. • Onchocerciasis – Cutaneous and subcutaneous nodules identified with ultrasound and magnetic resonance imaging.
• Dracunculiasis – Standard radiography reveal calcified worms.
• Dirofilariasis – Larvae can become encapsulated within necrotic lung tissue, resulting in distinct pulmonary nodules that may be detectable on computed tomography images.
DIFFERENTIAL DIAGNOSIS
Bancroftian and Malayan filariasis include bacterial lymphangitis, thrombophlebitis, idiopathic hydrocele, congestive heart failure, cirrhosis, and nephrotic syndrome. • Loiasis
– Cutaneous larva migrans, dracunculiasis, gnathostomiasis, myiasis, onchocerciasis • Onchocerciasis – M. streptocerca, scabies, leprosy, eczema, glaucoma, loiasis • Dracunculiasis – Cutaneous larva migrans, loiasis, rat bite infection, gnathostomiasis, myiasis • Dirofilariasis – Asthma, allergies, lung cancer • Mansonelliasis – Loiasis, onchocerciasis
INITIAL THERAPEUTIC AGENT
• Bancroftian and Malayan filariasis — Wolbachia spp., a genus of Rickettsia, are essential for filarial growth. Administer Doxycycline 100 mg orally twice daily for a duration of 4 to 6 weeks to address Wolbachia. Four months subsequent to initiating treatment, a single dosage of albendazole 400 mg orally and ivermectin 150 mg/kg orally was administered.
• Loiasis - Administer a single dosage of diethylcarbamazine citrate (DEC) at 6 mg/kg orally.
• Onchocerciasis - Administer one dosage of ivermectin at 150 mcg/kg orally (ineffective against mature worms). Recur in six months.
– Administer prednisone at a dosage of 1 mg/kg/day orally one week prior to ivermectin if ocular involvement is present.
• Dracunculiasis – Gradual and meticulous removal of the protruding worm.
Metronidazole 250 mg administered orally three times daily may
Mitigate inflammatory response, hence aiding in the expulsion of worms. Mebendazole 400–800 mg each day for 6 days may eradicate the worm.
• M. perstans – Administer albendazole 400 mg orally twice daily for 10 days. • M. streptocerca and M. ozzardi – Administer a single dose of ivermectin at 200 mcg/kg. • Dirofilariasis – No effective pharmacological treatment available. Second Line
• Bancroftian and Malayan filariasis – DEC, as previously mentioned for M. streptocerca. DEC should not be administered in regions with endemic lymphatic filariasis and loiasis/onchocerciasis.
SUPPLEMENTARY THERAPY
Comprehensive Measures
The treatment primarily targets the microfilarial stage of the infection. Adult worms are seldom impacted by a single dose of medicine. Repetitive therapy is frequently required for a cure.
Concerns for Referral
• Specialists in infectious diseases • Ophthalmologist for ocular assessment in onchocerciasis
CHIRURGICAL INTERVENTIONS/ADDITIONAL PROCEDURES
• Nodulectomy of palpable nodules in onchocerciasis • Surgical excision of dirofilariasis from the lung IN-PATIENT CONSIDERATIONS
Preliminary Stabilization
Resuscitation in accordance with advanced life support protocols as necessary
Criteria for Admission
• Patients with septicemia resulting from open wounds • Overnight admission for nocturnal blood sample collection for diagnostic testing
IV Fluids • Administer fluid resuscitation using colloids, such as Gelofusine, in cases of septicemia.
• Maintenance fluids utilizing Ringer's lactate
Nursing
Patients with elephantiasis may require comprehensive nursing care for the affected body portion.
Release Criteria for the resolution of septicemia
CONTINUING CARE POST-TREATMENT RECOMMENDATIONS
Every 4 to 6 weeks for treatment evaluation and symptomatic management
Patient Surveillance
Routine ocular assessments
OUTLOOK
Disability and disfigurement are mitigated by accurate diagnosis and therapy.
COMPLICATIONS
Bancroftian filariasis - Elephantiasis; Septicemia resulting from bacterial infection of exposed sores.
• Onchocerciasis - Visual Impairment
- Published on
Symptoms and Signs – Differential Diagnosis of Murmurs
Auscultatory murmurs are noises detected within the heart chambers or main arteries. They are categorized according on their timing and length within the cardiac cycle, auscultatory site, intensity, configuration, pitch, and quality.
Timing may be classified as systolic (between S1 and S2), holosystolic (persistent throughout systole), diastolic (between S2 and S1), or continuous across both systole and diastole; systolic and diastolic murmurs can additionally be categorized as early, mid, or late.
Location denotes the region of peak audibility, including the apex, the lower left sternal boundary, or an intercostal space. Loudness is assessed on a scale from 1 to 6. A grade 1 murmur is exceedingly subtle, discernible just by meticulous auscultation. A grade 2 murmur is a faint yet discernible murmur. Murmurs classified as grade 3 are of moderate loudness. A grade 4 murmur is a pronounced murmur accompanied with a potential intermittent thrill. Grade 5 murmurs are pronounced and accompanied by a detectable precordial thrill. Grade 6 murmurs are pronounced and, similar to grade 5 murmurs, are accompanied by a palpable excitement. A grade 6 murmur is discernible even after the stethoscope is removed from the thoracic wall.
Configuration, or shape, pertains to the characteristics of loudness — crescendo (increases in volume), decrescendo (decreases in volume), crescendo-decrescendo (first rises, then falls), decrescendo-crescendo (initially falls, then rises), plateau (constant intensity), or varied (inconsistent intensity). The pitch of the murmur may be elevated or diminished. The quality might be characterized as harsh, rumbling, blowing, scratching, buzzing, melodic, or squeaking.
Murmurs may indicate increased blood flow through either normal or pathological conditions. Valves facilitate forward blood flow through a constricted or irregular valve or into a dilated channel; let blood backflow through an incompetent valve, septal defect, or patent ductus arteriosus; or result in decreased blood viscosity. Murmurs, typically indicative of organic heart illness, may occasionally denote an emergency; for instance, a pronounced holosystolic murmur following an acute myocardial infarction (MI) may indicate papillary muscle rupture or a ventricular septal defect. Murmurs may also arise with the surgical implantation of a replacement valve.
Certain murmurs are benign or functioning. An innocent systolic murmur is often quiet, medium-pitched, and most pronounced along the left sternal border at the second or third intercostal space. It is intensified by physical exertion, agitation, fever, pregnancy, anemia, or thyrotoxicosis. Examples include Still's murmur in children and mammary souffle, typically auscultated across either breast during late pregnancy and early postpartum periods.
Medical History and Physical Assessment
Upon detecting a murmur, endeavor to ascertain its classification by meticulous auscultation.. Utilize the bell of your stethoscope for low-frequency murmurs and the diaphragm for high-frequency murmurs.
URGENT INTERVENTIONS
When Murmurs Indicate an Emergency Murmurs, particularly newly acquired ones, may indicate a significant complication in individuals with bacterial endocarditis or a recent acute myocardial infarction (MI), while not typically being an emergency sign.
When managing a patient with confirmed or suspected bacterial endocarditis, meticulously auscultate for the presence of new murmurs. Their advancement, accompanied by crackles, jugular vein distention, orthopnea, and dyspnea, these symptoms may indicate heart failure.
Consistent auscultation is crucial for a patient who has suffered an acute myocardial infarction. A pronounced decrescendo holosystolic murmur at the apex, radiating to the axilla and left sternal border or throughout the chest, is noteworthy, especially when accompanied by a widely divided S2 and an atrial gallop (S4). The presence of this murmur, alongside indications of severe pulmonary edema, typically signifies the onset of acute mitral regurgitation resulting from the rupture of the chordae tendineae – a medical emergency.
Subsequently, acquire the patient's medical history. Inquire whether the murmur is a recent finding or if it has been recognized since birth or infancy. Determine whether the patient has encountered concomitant symptoms, specifically palpitations, dizziness, syncope, chest discomfort, dyspnea, and weariness. Examine the patient's medical history, with specific attention to any occurrences of rheumatic fever, heart disease, or heart surgery, especially prosthetic valve replacement.
Conduct a methodical physical assessment. Particularly observe the occurrence of cardiac arrhythmias, jugular vein distention, and pulmonary manifestations like dyspnea, orthopnea, and crackles. Is the patient's liver painful or palpable? Does he exhibit peripheral edema?
Etiological Factors
Aortic regurgitation.
Acute aortic insufficiency generally generates a quiet, brief diastolic murmur along the left sternal boundary, most audible when the patient is seated and leans forward, as well as at the conclusion of a forced expiration. S2 may be diminished or missing. A quiet, brief midsystolic murmur may occasionally be auscultated above the second right intercostal region. Accompanying findings consist of tachycardia, dyspnea, jugular vein distention, crackles, heightened tiredness, and pale, chilly extremities.
Chronic aortic insufficiency produces a high-pitched, blown, decrescendo diastolic murmur, optimally auscultated over the second or third right intercostal space or the left sternal border, with the patient in a seated position, leaning forward, and holding their breath following deep expiration. An Austin Flint murmur — a low-frequency, mid-to-late diastolic murmur most prominently detected near the apex — may also manifest. Complications may not manifest until the patient reaches ages 40 to 50; subsequent observations typically include palpitations, tachycardia, angina, heightened tiredness, dyspnea, orthopnea, and crackles.
Aortic stenosis
The murmur associated with aortic stenosis is systolic, commencing after S1 and concluding at or prior to the closing of the aortic valve. It is abrasive and jarring, of medium pitch, exhibiting a crescendo and decrescendo. The murmur is most pronounced over the second right intercostal space when the patient is seated and leaning forward; it may also be audible at the apex, the suprasternal notch (Erb’s point), and the carotid arteries.
In cases of advanced disease, S2 may be perceived as a singular sound, with aortic closure being inaudible. An early systolic ejection click at the apex is characteristic but is missing in cases of extensive valve calcification. Associated signs and symptoms often manifest by age 30 in congenital aortic stenosis, between ages 30 and 65 in rheumatic disease-related stenosis, and post age 65 in calcific aortic stenosis. Symptoms may encompass dizziness, syncope, exertional dyspnea, paroxysmal nocturnal dyspnea, weariness, and angina.
Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy produces a pronounced late systolic murmur that concludes at S2. The murmur is best detected around the left sternal border and at the apex, often accompanied by an audible S3 or S4. The murmur diminishes with squatting and intensifies with sitting. Primary related symptoms include dyspnea and chest discomfort; palpitations, disorientation, and syncope may additionally manifest.
Mitral regurgitation
Acute mitral insufficiency is marked by a medium-pitched, blown, early systolic or holosystolic decrescendo murmur near the apex, accompanied by a widely split S2 and frequently an S4. This murmur does not intensify during inspiration, unlike tricuspid insufficiency. Commonly observed findings often encompass tachycardia and indications of acute pulmonary edema.
Chronic mitral insufficiency results in a high-pitched, blowing, holosystolic plateau murmur that is most pronounced at the apex and typically radiates to the axilla or back. Fatigue, dyspnea, and palpitations may additionally manifest.
Mitral valve prolapse
Mitral prolapse produces a midsystolic to late-systolic click accompanied by a high-pitched late-systolic crescendo murmur, most prominently audible at the apex. Intermittently, many clicks may be audible, with or without a systolic murmur. Related symptoms encompass cardiac awareness, migraine headaches, dizziness, weakness, syncope, palpitations, chest discomfort, dyspnea, significant episodic fatigue, mood fluctuations, and anxiety.
Mitral stenosis
In mitral stenosis, the murmur is characterized as mild, low-pitched, rumbling, crescendo-decrescendo, and diastolic, often accompanied by a pronounced S1 or an opening snap, which is a key indicator. The optimal auscultation occurs at the apex with the patient positioned laterally to the left. Moderate exertion facilitates the audibility of this murmur.
In cases of severe stenosis, a murmur indicative of mitral regurgitation may be audible. Additional observations encompass hemoptysis, exertional dyspnea, tiredness, and indications of acute pulmonary edema.
Myxomas
A left atrial myxoma, the most prevalent type, typically generates a middiastolic murmur and a holosystolic murmur that is most pronounced at the apex, accompanied by an S4, an early diastolic thudding sound (tumor plop), and a loud, widely divided S1. Associated symptoms including dyspnea, orthopnea, thoracic discomfort, exhaustion, weight reduction, and syncope.
A right atrial myxoma produces a late diastolic rumbling murmur, a holosystolic crescendo murmur, and a tumor plop, most prominently audible near the lower left sternal boundary. Additional findings including tiredness, peripheral edema, ascites, and hepatomegaly.
A left ventricular myxoma, which is rare, generates a systolic murmur most prominently detected at the lower left sternal border, along with arrhythmias, dyspnea, and syncope.
A right ventricular myxoma typically produces a systolic ejection murmur accompanied by a delayed S2 and a tumor plop, most prominently audible near the left sternal boundary. It is associated with peripheral edema, hepatomegaly, ascites, dyspnea, and syncope.
Rupture of the papillary muscle
A loud holosystolic murmur can be auscultated near the apex in cases of papillary muscle rupture, a life-threatening consequence of acute myocardial infarction. Associated findings encompass significant dyspnea, thoracic discomfort, syncope, hemoptysis, tachycardia, and hypotension.
Rheumatic fever accompanied by pericarditis
A pericardial friction rub, accompanied by murmurs and gallops, is optimally auscultated when the patient is positioned on hands and knees during forced expiration. The predominant murmurs detected include the systolic murmur of mitral regurgitation, a midsystolic murmur resulting from mitral valve leaflet edema, and the diastolic murmur of aortic regurgitation. Additional signs and symptoms encompass fever, joint and sternal discomfort, edema, and tachypnea.
Tricuspid regurgitation
Tricuspid insufficiency is a valve disorder characterized by a mild, high-pitched, holosystolic blowing murmur that intensifies with inspiration (Carvallo’s sign), diminishes with exhale and Valsalva maneuver, and is optimally auscultated over the lower left sternal border and the xiphoid region. After an extended asymptomatic phase, symptoms such as exertional dyspnea and orthopnea may manifest, accompanied by jugular vein distention, ascites, peripheral cyanosis and edema, muscle wasting, lethargy, weakness, and syncope.
Tricuspid stenosis
Tricuspid stenosis is a valve condition that generates a diastolic murmur like to that of mitral stenosis, although more pronounced during inspiration and diminished during exhale and the Valsalva maneuver. S1 may also exhibit increased loudness. Accompanying signs and symptoms encompass fatigue, syncope, peripheral edema, jugular vein distention, ascites, hepatomegaly, and dyspnea.
Alternative Causes
Therapies. Prosthetic valve replacement can produce diverse murmurs, influenced by the location, valve material, and operational technique.
Particular Considerations
Prepare the patient for diagnostic procedures, including electrocardiography, echocardiography, and angiography. Administer an antibiotic and an anticoagulant as indicated. Due to the distressing nature of a heart problem, offer emotional support.
Patient Consultation
Detail the indications and symptoms the patient must communicate and the applicability of prophylactic antibiotics, if relevant.
Pediatric Guidelines
Innocuous murmurs, such as Still's murmur, are frequently seen in young children and generally resolve after puberty. Pathognomonic heart murmurs in newborns and young children typically arise from congenital heart disease, including atrial and ventricular septal abnormalities. Additional murmurs may be acquired, as seen in rheumatic heart disease.
Auscultatory murmurs are noises detected within the heart chambers or main arteries. They are categorized according on their timing and length within the cardiac cycle, auscultatory site, intensity, configuration, pitch, and quality.
Timing may be classified as systolic (between S1 and S2), holosystolic (persistent throughout systole), diastolic (between S2 and S1), or continuous across both systole and diastole; systolic and diastolic murmurs can additionally be categorized as early, mid, or late.
Location denotes the region of peak audibility, including the apex, the lower left sternal boundary, or an intercostal space. Loudness is assessed on a scale from 1 to 6. A grade 1 murmur is exceedingly subtle, discernible just by meticulous auscultation. A grade 2 murmur is a faint yet discernible murmur. Murmurs classified as grade 3 are of moderate loudness. A grade 4 murmur is a pronounced murmur accompanied with a potential intermittent thrill. Grade 5 murmurs are pronounced and accompanied by a detectable precordial thrill. Grade 6 murmurs are pronounced and, similar to grade 5 murmurs, are accompanied by a palpable excitement. A grade 6 murmur is discernible even after the stethoscope is removed from the thoracic wall.
Configuration, or shape, pertains to the characteristics of loudness — crescendo (increases in volume), decrescendo (decreases in volume), crescendo-decrescendo (first rises, then falls), decrescendo-crescendo (initially falls, then rises), plateau (constant intensity), or varied (inconsistent intensity). The pitch of the murmur may be elevated or diminished. The quality might be characterized as harsh, rumbling, blowing, scratching, buzzing, melodic, or squeaking.
Murmurs may indicate increased blood flow through either normal or pathological conditions. Valves facilitate forward blood flow through a constricted or irregular valve or into a dilated channel; let blood backflow through an incompetent valve, septal defect, or patent ductus arteriosus; or result in decreased blood viscosity. Murmurs, typically indicative of organic heart illness, may occasionally denote an emergency; for instance, a pronounced holosystolic murmur following an acute myocardial infarction (MI) may indicate papillary muscle rupture or a ventricular septal defect. Murmurs may also arise with the surgical implantation of a replacement valve.
Certain murmurs are benign or functioning. An innocent systolic murmur is often quiet, medium-pitched, and most pronounced along the left sternal border at the second or third intercostal space. It is intensified by physical exertion, agitation, fever, pregnancy, anemia, or thyrotoxicosis. Examples include Still's murmur in children and mammary souffle, typically auscultated across either breast during late pregnancy and early postpartum periods.
Medical History and Physical Assessment
Upon detecting a murmur, endeavor to ascertain its classification by meticulous auscultation.. Utilize the bell of your stethoscope for low-frequency murmurs and the diaphragm for high-frequency murmurs.
URGENT INTERVENTIONS
When Murmurs Indicate an Emergency Murmurs, particularly newly acquired ones, may indicate a significant complication in individuals with bacterial endocarditis or a recent acute myocardial infarction (MI), while not typically being an emergency sign.
When managing a patient with confirmed or suspected bacterial endocarditis, meticulously auscultate for the presence of new murmurs. Their advancement, accompanied by crackles, jugular vein distention, orthopnea, and dyspnea, these symptoms may indicate heart failure.
Consistent auscultation is crucial for a patient who has suffered an acute myocardial infarction. A pronounced decrescendo holosystolic murmur at the apex, radiating to the axilla and left sternal border or throughout the chest, is noteworthy, especially when accompanied by a widely divided S2 and an atrial gallop (S4). The presence of this murmur, alongside indications of severe pulmonary edema, typically signifies the onset of acute mitral regurgitation resulting from the rupture of the chordae tendineae – a medical emergency.
Subsequently, acquire the patient's medical history. Inquire whether the murmur is a recent finding or if it has been recognized since birth or infancy. Determine whether the patient has encountered concomitant symptoms, specifically palpitations, dizziness, syncope, chest discomfort, dyspnea, and weariness. Examine the patient's medical history, with specific attention to any occurrences of rheumatic fever, heart disease, or heart surgery, especially prosthetic valve replacement.
Conduct a methodical physical assessment. Particularly observe the occurrence of cardiac arrhythmias, jugular vein distention, and pulmonary manifestations like dyspnea, orthopnea, and crackles. Is the patient's liver painful or palpable? Does he exhibit peripheral edema?
Etiological Factors
Aortic regurgitation.
Acute aortic insufficiency generally generates a quiet, brief diastolic murmur along the left sternal boundary, most audible when the patient is seated and leans forward, as well as at the conclusion of a forced expiration. S2 may be diminished or missing. A quiet, brief midsystolic murmur may occasionally be auscultated above the second right intercostal region. Accompanying findings consist of tachycardia, dyspnea, jugular vein distention, crackles, heightened tiredness, and pale, chilly extremities.
Chronic aortic insufficiency produces a high-pitched, blown, decrescendo diastolic murmur, optimally auscultated over the second or third right intercostal space or the left sternal border, with the patient in a seated position, leaning forward, and holding their breath following deep expiration. An Austin Flint murmur — a low-frequency, mid-to-late diastolic murmur most prominently detected near the apex — may also manifest. Complications may not manifest until the patient reaches ages 40 to 50; subsequent observations typically include palpitations, tachycardia, angina, heightened tiredness, dyspnea, orthopnea, and crackles.
Aortic stenosis
The murmur associated with aortic stenosis is systolic, commencing after S1 and concluding at or prior to the closing of the aortic valve. It is abrasive and jarring, of medium pitch, exhibiting a crescendo and decrescendo. The murmur is most pronounced over the second right intercostal space when the patient is seated and leaning forward; it may also be audible at the apex, the suprasternal notch (Erb’s point), and the carotid arteries.
In cases of advanced disease, S2 may be perceived as a singular sound, with aortic closure being inaudible. An early systolic ejection click at the apex is characteristic but is missing in cases of extensive valve calcification. Associated signs and symptoms often manifest by age 30 in congenital aortic stenosis, between ages 30 and 65 in rheumatic disease-related stenosis, and post age 65 in calcific aortic stenosis. Symptoms may encompass dizziness, syncope, exertional dyspnea, paroxysmal nocturnal dyspnea, weariness, and angina.
Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy produces a pronounced late systolic murmur that concludes at S2. The murmur is best detected around the left sternal border and at the apex, often accompanied by an audible S3 or S4. The murmur diminishes with squatting and intensifies with sitting. Primary related symptoms include dyspnea and chest discomfort; palpitations, disorientation, and syncope may additionally manifest.
Mitral regurgitation
Acute mitral insufficiency is marked by a medium-pitched, blown, early systolic or holosystolic decrescendo murmur near the apex, accompanied by a widely split S2 and frequently an S4. This murmur does not intensify during inspiration, unlike tricuspid insufficiency. Commonly observed findings often encompass tachycardia and indications of acute pulmonary edema.
Chronic mitral insufficiency results in a high-pitched, blowing, holosystolic plateau murmur that is most pronounced at the apex and typically radiates to the axilla or back. Fatigue, dyspnea, and palpitations may additionally manifest.
Mitral valve prolapse
Mitral prolapse produces a midsystolic to late-systolic click accompanied by a high-pitched late-systolic crescendo murmur, most prominently audible at the apex. Intermittently, many clicks may be audible, with or without a systolic murmur. Related symptoms encompass cardiac awareness, migraine headaches, dizziness, weakness, syncope, palpitations, chest discomfort, dyspnea, significant episodic fatigue, mood fluctuations, and anxiety.
Mitral stenosis
In mitral stenosis, the murmur is characterized as mild, low-pitched, rumbling, crescendo-decrescendo, and diastolic, often accompanied by a pronounced S1 or an opening snap, which is a key indicator. The optimal auscultation occurs at the apex with the patient positioned laterally to the left. Moderate exertion facilitates the audibility of this murmur.
In cases of severe stenosis, a murmur indicative of mitral regurgitation may be audible. Additional observations encompass hemoptysis, exertional dyspnea, tiredness, and indications of acute pulmonary edema.
Myxomas
A left atrial myxoma, the most prevalent type, typically generates a middiastolic murmur and a holosystolic murmur that is most pronounced at the apex, accompanied by an S4, an early diastolic thudding sound (tumor plop), and a loud, widely divided S1. Associated symptoms including dyspnea, orthopnea, thoracic discomfort, exhaustion, weight reduction, and syncope.
A right atrial myxoma produces a late diastolic rumbling murmur, a holosystolic crescendo murmur, and a tumor plop, most prominently audible near the lower left sternal boundary. Additional findings including tiredness, peripheral edema, ascites, and hepatomegaly.
A left ventricular myxoma, which is rare, generates a systolic murmur most prominently detected at the lower left sternal border, along with arrhythmias, dyspnea, and syncope.
A right ventricular myxoma typically produces a systolic ejection murmur accompanied by a delayed S2 and a tumor plop, most prominently audible near the left sternal boundary. It is associated with peripheral edema, hepatomegaly, ascites, dyspnea, and syncope.
Rupture of the papillary muscle
A loud holosystolic murmur can be auscultated near the apex in cases of papillary muscle rupture, a life-threatening consequence of acute myocardial infarction. Associated findings encompass significant dyspnea, thoracic discomfort, syncope, hemoptysis, tachycardia, and hypotension.
Rheumatic fever accompanied by pericarditis
A pericardial friction rub, accompanied by murmurs and gallops, is optimally auscultated when the patient is positioned on hands and knees during forced expiration. The predominant murmurs detected include the systolic murmur of mitral regurgitation, a midsystolic murmur resulting from mitral valve leaflet edema, and the diastolic murmur of aortic regurgitation. Additional signs and symptoms encompass fever, joint and sternal discomfort, edema, and tachypnea.
Tricuspid regurgitation
Tricuspid insufficiency is a valve disorder characterized by a mild, high-pitched, holosystolic blowing murmur that intensifies with inspiration (Carvallo’s sign), diminishes with exhale and Valsalva maneuver, and is optimally auscultated over the lower left sternal border and the xiphoid region. After an extended asymptomatic phase, symptoms such as exertional dyspnea and orthopnea may manifest, accompanied by jugular vein distention, ascites, peripheral cyanosis and edema, muscle wasting, lethargy, weakness, and syncope.
Tricuspid stenosis
Tricuspid stenosis is a valve condition that generates a diastolic murmur like to that of mitral stenosis, although more pronounced during inspiration and diminished during exhale and the Valsalva maneuver. S1 may also exhibit increased loudness. Accompanying signs and symptoms encompass fatigue, syncope, peripheral edema, jugular vein distention, ascites, hepatomegaly, and dyspnea.
Alternative Causes
Therapies. Prosthetic valve replacement can produce diverse murmurs, influenced by the location, valve material, and operational technique.
Particular Considerations
Prepare the patient for diagnostic procedures, including electrocardiography, echocardiography, and angiography. Administer an antibiotic and an anticoagulant as indicated. Due to the distressing nature of a heart problem, offer emotional support.
Patient Consultation
Detail the indications and symptoms the patient must communicate and the applicability of prophylactic antibiotics, if relevant.
Pediatric Guidelines
Innocuous murmurs, such as Still's murmur, are frequently seen in young children and generally resolve after puberty. Pathognomonic heart murmurs in newborns and young children typically arise from congenital heart disease, including atrial and ventricular septal abnormalities. Additional murmurs may be acquired, as seen in rheumatic heart disease.
- Published on
Infectious Disease - Erythema Nodosum
ERYTHEMA NODOSUM
FUNDAMENTALS OVERVIEW
Erythema nodosum is the most prevalent form of panniculitis. The clinical presentation includes inflammatory, painful, nodular lesions. The lesions are predominantly situated on the lower limbs.
EPIDEMIOLOGY
Incidence • The highest incidence is observed between the ages of 18 and 34 years. The annual incidence rate of biopsy-confirmed erythema nodosum in hospitalized patients aged 14 years and older was estimated at 52 occurrences per million individuals. • Predominantly observed in females.
Prevalence • 2.4 cases per 1,000 individuals annually. • Seasonal aggregation of sarcoidosis presenting with erythema nodosum has also been documented. Clustering peaked in August, September, and October.
RISK FACTORS: Genetics Particular human leukocyte antigens, HLA-B8 and HLA-DR3, were identified as correlated with the occurrence of erythema nodosum in sarcoidosis.
PATHOPHYSIOLOGY
Erythema nodosum can be classified as a type IV delayed hypersensitivity reaction to many antigens.
CAUSES
Multiple etiological variables have been linked to erythema nodosum: Bacterial infections: Streptococcal infections (Group A beta-hemolytic Streptococcus) are the most prevalent infectious etiologies of erythema nodosum, along with mycobacterial infections (Hansen's bacillus, tuberculosis), brucellosis, cat-scratch disease, and Yersinia enterocolitica. Syphilis, along with infections caused by Salmonella spp. (S. enteritidis and S. typhi), Mycoplasma spp., Chlamydia spp. (including C. psittaci, C. pneumoniae, and C. trachomatis), Neisseria meningitidis, N. gonorrhoeae, Francisella tularensis, and Rickettsiae spp., may also induce erythema nodosum. • Viral infections: Cytomegalovirus (CMV), Epstein-Barr virus (EBV), Human Immunodeficiency Virus (HIV), Hepatitis B virus (HBV), Herpes Simplex Virus (HSV) • Fungal infections: Coccidioidomycosis, aspergillosis, histoplasmosis • Protozoal infections: Amebiasis, toxoplasmosis, giardiasis • Pharmacological agents: Sulphonamides, sulfones, bromides, oral contraceptives • Malignancies: Hodgkin’s disease, non-Hodgkin’s lymphoma, leukemia, pancreatic carcinoma, colon adenocarcinoma • Other pathological conditions: Sarcoidosis, Adamantiades–Behcet’s disease, Crohn’s disease, ulcerative colitis, Sweet’s syndrome, lupus erythematosus, Sjögren’s syndrome • Gestation • Idiopathic (likely the predominant etiology)
DIAGNOSIS HISTORY
• Diligent medical history acquisition is critically significant. • Abrupt emergence of painful, erythematous nodules and elevated plaques typically found on the shins, ankles, and knees. • Erythema nodosum frequently presents with fever ranging from approximately 38–39°C, along with exhaustion and joint pain. • Generally self-resolving within several weeks.
PHYSICAL EXAM • Erythematous, sensitive red nodules and elevated plaques situated on the shins, ankles, knees, and infrequently on the extensor surfaces of the arms, neck, or face. Initially, the nodules exhibit a vivid red hue and are elevated; however, within a few days, they flatten and assume a livid red or purplish tint. Ultimately, they transition to a yellow or greenish hue and frequently resemble a pronounced bruise (“erythema contusiformis”). The nodules resolve without atrophy or scarring. Ulceration is never noticed.
DIAGNOSTIC TESTS AND INTERPRETATION LAB • Complete blood count • Erythrocyte sedimentation rate • Antistreptolysin O titer • Rapid antigen test for streptococcus • Polymerase chain reaction for streptococcal DNA detection • Throat culture • Urinalysis • Intradermal tuberculin test Chest radiograph (tuberculosis, bilateral hilar lymphadenopathy [Lofgren’s syndrome])
Diagnostic Procedures and Additional Methods
• Evaluate stool culture and parasite examination if abdominal pain, bloating, or diarrhea is present. • Conduct a punch biopsy of the skin. • Perform a transbronchial lung biopsy for histological confirmation of sarcoidosis. • Execute a biopsy of the gastrocnemius muscle, as myopathy is frequently observed in Lofgren’s syndrome. • Administer an interferon-γ release assay. • Consider colonoscopy to exclude inflammatory bowel disease. Pathological Observations The histopathologic hallmark is the presence of "Miescher's radial granulomas." It comprises discrete, distinct nodular clusters of histiocytes surrounding a central cleft. Additionally, infiltration of polymorphonuclear leukocytes is another histopathological observation.
DIFFERENTIAL DIAGNOSIS • Erythema induratum of Bazin: – Histopathological distinctions: Erythema induratum of Bazin mostly presents as lobular panniculitis, in contrast to erythema nodosum, which predominantly exhibits septal panniculitis. The nodules of erythema induratum of Bazin are primarily situated on the posterior aspect of the legs, exhibit greater persistence, and may also present with ulceration. • Dermatological manifestations of superficial thrombophlebitis: The lesions are predominantly situated on the lateral aspects of the legs and present as firm, irregular, fibrotic cords or plaques. The biopsy indicates minimal to no signs of inflammatory infiltration, suggesting a vasculitic rather than a panniculitic disease. • Lyme disease • Etiologies of panniculitis (e.g., systemic lupus erythematosus [SLE], acute pancreatitis)
TREATMENT MEDICATION
Initial Line Erythema nodosum is predominantly self-limiting, resolving in most individuals within several weeks. Treatment must be tailored to the underlying condition. • Symptomatic management may involve nonsteroidal anti-inflammatory medications (NSAIDs): Indomethacin 100–150 mg daily, naproxen 500 mg daily. Avoid NSAIDs if the etiology is inflammatory bowel illness. • Steroids may be administered in severe situations when infectious etiologies or malignancies have been excluded. • Prednisone administered at a dosage of 1 mg/kg, gradually reduced over many days. • Potassium iodide: The maximum dosage for adults is 300 mg administered three times daily. Nonetheless, significant secondary hyperthyroidism may arise. • Hydroxychloroquine (specifically for persistent erythema nodosum; 200 mg bi-daily). Colchicine (effective for erythema nodosum linked to Adamantiades–Behcet’s illness; 1–2 mg daily, administered in two doses). Erythema nodosum leprosum: Evidence exists supporting the efficacy of thalidomide and clofazimine. Furthermore, a markedly reduced incidence of mild side events was observed with a low-dose thalidomide regimen in comparison to a high-dose regimen . Second Line: Infliximab is indicated for erythema nodosum linked to inflammatory bowel illness.
SUPPLEMENTARY THERAPY
General Measures: • Bed rest • Consistent elevation • Compression
CONTINUING TREATMENT OUTLOOK • Most cases cure within 3 to 4 weeks. • Recurrence is infrequent, however more prevalent in idiopathic cases of erythema nodosum and in those associated with upper respiratory tract infections (either streptococcal or non-streptococcal).
COMPLICATIONS • Optic nerve neuritis has been documented in a patient during an acute episode of erythema nodosum.
ERYTHEMA NODOSUM
FUNDAMENTALS OVERVIEW
Erythema nodosum is the most prevalent form of panniculitis. The clinical presentation includes inflammatory, painful, nodular lesions. The lesions are predominantly situated on the lower limbs.
EPIDEMIOLOGY
Incidence • The highest incidence is observed between the ages of 18 and 34 years. The annual incidence rate of biopsy-confirmed erythema nodosum in hospitalized patients aged 14 years and older was estimated at 52 occurrences per million individuals. • Predominantly observed in females.
Prevalence • 2.4 cases per 1,000 individuals annually. • Seasonal aggregation of sarcoidosis presenting with erythema nodosum has also been documented. Clustering peaked in August, September, and October.
RISK FACTORS: Genetics Particular human leukocyte antigens, HLA-B8 and HLA-DR3, were identified as correlated with the occurrence of erythema nodosum in sarcoidosis.
PATHOPHYSIOLOGY
Erythema nodosum can be classified as a type IV delayed hypersensitivity reaction to many antigens.
CAUSES
Multiple etiological variables have been linked to erythema nodosum: Bacterial infections: Streptococcal infections (Group A beta-hemolytic Streptococcus) are the most prevalent infectious etiologies of erythema nodosum, along with mycobacterial infections (Hansen's bacillus, tuberculosis), brucellosis, cat-scratch disease, and Yersinia enterocolitica. Syphilis, along with infections caused by Salmonella spp. (S. enteritidis and S. typhi), Mycoplasma spp., Chlamydia spp. (including C. psittaci, C. pneumoniae, and C. trachomatis), Neisseria meningitidis, N. gonorrhoeae, Francisella tularensis, and Rickettsiae spp., may also induce erythema nodosum. • Viral infections: Cytomegalovirus (CMV), Epstein-Barr virus (EBV), Human Immunodeficiency Virus (HIV), Hepatitis B virus (HBV), Herpes Simplex Virus (HSV) • Fungal infections: Coccidioidomycosis, aspergillosis, histoplasmosis • Protozoal infections: Amebiasis, toxoplasmosis, giardiasis • Pharmacological agents: Sulphonamides, sulfones, bromides, oral contraceptives • Malignancies: Hodgkin’s disease, non-Hodgkin’s lymphoma, leukemia, pancreatic carcinoma, colon adenocarcinoma • Other pathological conditions: Sarcoidosis, Adamantiades–Behcet’s disease, Crohn’s disease, ulcerative colitis, Sweet’s syndrome, lupus erythematosus, Sjögren’s syndrome • Gestation • Idiopathic (likely the predominant etiology)
DIAGNOSIS HISTORY
• Diligent medical history acquisition is critically significant. • Abrupt emergence of painful, erythematous nodules and elevated plaques typically found on the shins, ankles, and knees. • Erythema nodosum frequently presents with fever ranging from approximately 38–39°C, along with exhaustion and joint pain. • Generally self-resolving within several weeks.
PHYSICAL EXAM • Erythematous, sensitive red nodules and elevated plaques situated on the shins, ankles, knees, and infrequently on the extensor surfaces of the arms, neck, or face. Initially, the nodules exhibit a vivid red hue and are elevated; however, within a few days, they flatten and assume a livid red or purplish tint. Ultimately, they transition to a yellow or greenish hue and frequently resemble a pronounced bruise (“erythema contusiformis”). The nodules resolve without atrophy or scarring. Ulceration is never noticed.
DIAGNOSTIC TESTS AND INTERPRETATION LAB • Complete blood count • Erythrocyte sedimentation rate • Antistreptolysin O titer • Rapid antigen test for streptococcus • Polymerase chain reaction for streptococcal DNA detection • Throat culture • Urinalysis • Intradermal tuberculin test Chest radiograph (tuberculosis, bilateral hilar lymphadenopathy [Lofgren’s syndrome])
Diagnostic Procedures and Additional Methods
• Evaluate stool culture and parasite examination if abdominal pain, bloating, or diarrhea is present. • Conduct a punch biopsy of the skin. • Perform a transbronchial lung biopsy for histological confirmation of sarcoidosis. • Execute a biopsy of the gastrocnemius muscle, as myopathy is frequently observed in Lofgren’s syndrome. • Administer an interferon-γ release assay. • Consider colonoscopy to exclude inflammatory bowel disease. Pathological Observations The histopathologic hallmark is the presence of "Miescher's radial granulomas." It comprises discrete, distinct nodular clusters of histiocytes surrounding a central cleft. Additionally, infiltration of polymorphonuclear leukocytes is another histopathological observation.
DIFFERENTIAL DIAGNOSIS • Erythema induratum of Bazin: – Histopathological distinctions: Erythema induratum of Bazin mostly presents as lobular panniculitis, in contrast to erythema nodosum, which predominantly exhibits septal panniculitis. The nodules of erythema induratum of Bazin are primarily situated on the posterior aspect of the legs, exhibit greater persistence, and may also present with ulceration. • Dermatological manifestations of superficial thrombophlebitis: The lesions are predominantly situated on the lateral aspects of the legs and present as firm, irregular, fibrotic cords or plaques. The biopsy indicates minimal to no signs of inflammatory infiltration, suggesting a vasculitic rather than a panniculitic disease. • Lyme disease • Etiologies of panniculitis (e.g., systemic lupus erythematosus [SLE], acute pancreatitis)
TREATMENT MEDICATION
Initial Line Erythema nodosum is predominantly self-limiting, resolving in most individuals within several weeks. Treatment must be tailored to the underlying condition. • Symptomatic management may involve nonsteroidal anti-inflammatory medications (NSAIDs): Indomethacin 100–150 mg daily, naproxen 500 mg daily. Avoid NSAIDs if the etiology is inflammatory bowel illness. • Steroids may be administered in severe situations when infectious etiologies or malignancies have been excluded. • Prednisone administered at a dosage of 1 mg/kg, gradually reduced over many days. • Potassium iodide: The maximum dosage for adults is 300 mg administered three times daily. Nonetheless, significant secondary hyperthyroidism may arise. • Hydroxychloroquine (specifically for persistent erythema nodosum; 200 mg bi-daily). Colchicine (effective for erythema nodosum linked to Adamantiades–Behcet’s illness; 1–2 mg daily, administered in two doses). Erythema nodosum leprosum: Evidence exists supporting the efficacy of thalidomide and clofazimine. Furthermore, a markedly reduced incidence of mild side events was observed with a low-dose thalidomide regimen in comparison to a high-dose regimen . Second Line: Infliximab is indicated for erythema nodosum linked to inflammatory bowel illness.
SUPPLEMENTARY THERAPY
General Measures: • Bed rest • Consistent elevation • Compression
CONTINUING TREATMENT OUTLOOK • Most cases cure within 3 to 4 weeks. • Recurrence is infrequent, however more prevalent in idiopathic cases of erythema nodosum and in those associated with upper respiratory tract infections (either streptococcal or non-streptococcal).
COMPLICATIONS • Optic nerve neuritis has been documented in a patient during an acute episode of erythema nodosum.
- Published on
Infectious Disease - Infective Esophagitis
FUNDAMENTAL DESCRIPTION
Esophageal infection caused by various fungus, viruses, and bacteria
EPIDEMIOLOGY Incidence
• Infectious esophagitis is uncommon in individuals with a normal immune system but prevalent among immunocompromised patients, those on medications that alter the normal esophageal microflora or immune function, and in cases where abnormalities impede the clearance of the esophageal lumen. • Primary cytomegalovirus (CMV) infections are prevalent in preschool children and young adults. Nonetheless, they infrequently induce esophagitis in immunocompetent individuals.
RISK FACTORS
• Immune deficiencies • Pharmacological agents that may modify immune function or esophageal microbiota • Anatomical anomalies or motility issues of the esophagus
GENERAL PREVENTION • Mitigation of risk factors, when feasible
• Suitable antiretroviral therapy to reduce immunosuppression in HIV-positive individuals
ETIOLOGY • The predominant etiological agents of infectious esophagitis in both immunocompromised and immunocompetent patients are one or a combination of the following three organisms: Candida spp., herpes simplex virus (HSV), and cytomegalovirus (CMV).
• The majority of Candida esophagitis cases are attributed to C. albicans. Diseases symptomatic of C. glabrata and C. krusei have also been documented.
• Other pathogens that may seldom induce infectious esophagitis include the following:
– Aspergillus species – Histoplasma species – Blastomyces dermatitidis – Varicella zoster virus
– Epstein–Barr virus – Human papillomavirus – Mycobacterium TB and Mycobacterium avium – Normal oropharyngeal flora (rarely) including Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus viridans, and Bacillus species – Acute HIV infection
HISTORY OF DIAGNOSIS
Dysphagia, odynophagia, or both are the most prevalent symptoms.
• Chronic chest pain is also prevalent.
• Additional nonspecific clinical signs, such as weight loss, may arise from these symptoms or indicate an underlying illness responsible for the esophagitis.
Local problems, such as hemorrhage, esophageal perforation, or fistula formation, may arise in the presence of deep esophageal ulcerations caused by infected esophagitis.
Infectious esophagitis might be asymptomatic. The prevalence of asymptomatic esophageal infections is indeterminate.
PHYSICAL EXAMINATION
CMV esophagitis may manifest with systemic symptoms (e.g., fever, nausea, vomiting, or abdominal pain), while Candida and HSV esophagitis typically arise.
Oral lesions. Nonetheless, these sporadic discrepancies are not distinctive. The lack of thrush does not exclude the possibility of Candida esophagitis.
DIAGNOSTIC TESTS AND INTERPRETATION Laboratory
• Hematologic profile • Serological testing for HSV, CMV, and HIV • CMV antigenemia assays or CMV molecular amplification methods
• Brush cytology specimens acquired via endoscopy for the diagnosis of Candida and HSV esophagitis. • Tissue culture for the diagnosis of HSV and CMV esophagitis. Culture is not typically advised for diagnosing Candida esophagitis. This is designated for instances exhibiting clinical characteristics indicative of a pathogen resistant to conventional antifungal treatment.
Imaging
Radiographic assessment following a barium swallow reveals an uneven, frayed look of the esophagus mucosa in instances of Candida esophagitis. At times, the image is indistinguishable from that observed in instances of HSV and CMV esophagitis.
Diagnostic Procedures/Other • Endoscopy and tissue sampling for histological evaluation or brush cytology.
The standard endoscopic presentation of Candida esophagitis features white plaques on the mucosa that frequently hemorrhage upon removal by the endoscope.
Endoscopy in HSV esophagitis demonstrates tiny, well-defined ulcers with a yellowish base. The esophageal mucosa between lesions may frequently appear normal. Shallow, elongated ulcerations, encircled by seemingly normal mucosa, may characterize the endoscopic presentation of CMV esophagitis. Nevertheless, the endoscopic characteristics of Candida, HSV, or CMV esophagitis may be indistinguishable.
Pathological Observations
• Endoscopic tissue specimens may reveal: – Budding yeast cells, hyphae, or pseudohyphae in Candida esophagitis – Multinucleated giant cells and intranuclear inclusion bodies in HSV esophagitis – Cytomegaly of fibroblasts and endothelial cells with intranuclear and cytoplasmic inclusion bodies in
CMV esophagitis.
DIFFERENTIAL DIAGNOSIS
• Esophageal carcinoma (primary or metastatic). • Systemic conditions including: – Crohn's disease
Sarcoidosis
Collagen vascular disorders
Pill esophagitis may occur following the administration of specific antibiotics (such as tetracycline, doxycycline, clindamycin, ciprofloxacin, among others), potassium chloride, nonsteroidal anti-inflammatory medications, and quinidine.
Chemotherapy-induced esophagitis (dactinomycin, bleomycin, cytarabine, methotrexate, and other agents).
• Esophagitis resulting from radiation or the simultaneous application of radiation and chemotherapy.
• Inflammation resulting from sclerotherapy of esophageal varices.
• Idiopathic (aphthous) esophageal ulcers associated with HIV infection.
Oral lesions are frequently observed in patients with Candida and HSV esophagitis, although CMV esophagitis is infrequently linked to stomatitis.
INITIAL THERAPY MEDICATION
Systemic antifungal therapy is invariably necessary for Candida esophagitis (A-II).
A diagnostic trial of antifungal medication is warranted prior to doing an endoscopic examination (B-II).
Oral fluconazole at a dosage of 200–400 mg (3–6 mg/kg) daily for a duration of 14–21 days is advised (A-I). For individuals unable to endure oral therapy: Administer intravenous fluconazole 400 mg (6 mg/kg) daily, deoxycholate amphotericin B 0.3–0.7 mg/kg daily, or an echinocandin (B-II).
For fluconazole-refractory disease: Itraconazole solution 200 mg daily, posaconazole suspension 400 mg twice daily, or voriconazole 200 mg twice daily, taken intravenously or orally for 14–21 days.
• For recurring infections: Administer suppressive therapy with fluconazole at a dosage of 100–200 mg three times weekly (3) (A-I).
• In individuals with AIDS, the use of HAART is advised to mitigate recurring infections (A-I).
HSV esophagitis typically resolves spontaneously in immunocompetent individuals.
Immunocompromised people ought to receive antiviral medications for a duration of 14 to 21 days. Acyclovir 400 mg orally five times daily, valacyclovir 1 g orally three times daily, famciclovir 500 mg orally three times daily. For individuals unable to endure oral therapy: Acyclovir 5 mg/kg intravenously every 8 hours for 7 to 14 days, succeeded by an oral antiviral for a minimum of 1 further week.
Prophylactic therapy with acyclovir at a dosage of 200–400 mg orally per day or 5 mg/kg intravenously twice day may be warranted in cases with elevated risk for HSV reactivation.
CMV esophagitis is managed with ganciclovir at a dosage of 5 mg/kg intravenously twice day for a minimum duration of 2 weeks.
Maintenance therapy with valganciclovir 900 mg orally daily may be required to prevent recurrence of CMV esophagitis in individuals with significant immunocompromise.
To avert CMV infection, CMV seronegative transplant recipients from seropositive donors should undergo antiviral prophylaxis.
Idiopathic (aphthous) esophageal ulcers in HIV infection are managed with prednisone or thalidomide.
Second Line
• For fluconazole-refractory Candida esophagitis: Micafungin 150 mg daily, caspofungin 50 mg daily, anidulafungin 200 mg daily, or deoxycholate
Amphotericin B 0.3–0.7 mg/kg per day (B-II).
• Echinocandins correlate with elevated relapse rates in comparison to fluconazole. • For ganciclovir-resistant HSV or CMV esophagitis: Foscarnet.
INPATIENT CONSIDERATIONS
Criteria for Admission
Outpatient care is suitable unless the patient's immune state is significantly weakened or the infection is exceedingly severe. In such instances, hospitalization may be required.
Intravenous Fluids
Should the patient endure significant odynophagia or if esophagitis is coupled with oral lesions that hinder chewing or swallowing, the provision of intravenous fluids may be requisite.
CONTINUING MANAGEMENT POST-TREATMENT SUGGESTIONS
The anticipated course and prognosis are contingent upon the underlying disease and pathogen; in cases of severe immunosuppression, extended therapy with efficacious drugs is required.
• Patients diagnosed with infectious esophagitis should schedule a follow-up appointment two weeks post-symptom resolution. • The majority of patients with Candida esophagitis typically experience symptom clearance within seven days of initiating treatment.
Myelosuppression is the primary adverse effect of ganciclovir therapy. The simultaneous use of zidovudine may exacerbate myelosuppression.
COMPLICATIONS
• Complications are rare. Severe local consequences may arise from deep esophageal ulcers, including massive hemorrhage.
– Esophageal perforation – Esophagobronchial or esophagomediastinal fistulas
FUNDAMENTAL DESCRIPTION
Esophageal infection caused by various fungus, viruses, and bacteria
EPIDEMIOLOGY Incidence
• Infectious esophagitis is uncommon in individuals with a normal immune system but prevalent among immunocompromised patients, those on medications that alter the normal esophageal microflora or immune function, and in cases where abnormalities impede the clearance of the esophageal lumen. • Primary cytomegalovirus (CMV) infections are prevalent in preschool children and young adults. Nonetheless, they infrequently induce esophagitis in immunocompetent individuals.
RISK FACTORS
• Immune deficiencies • Pharmacological agents that may modify immune function or esophageal microbiota • Anatomical anomalies or motility issues of the esophagus
GENERAL PREVENTION • Mitigation of risk factors, when feasible
• Suitable antiretroviral therapy to reduce immunosuppression in HIV-positive individuals
ETIOLOGY • The predominant etiological agents of infectious esophagitis in both immunocompromised and immunocompetent patients are one or a combination of the following three organisms: Candida spp., herpes simplex virus (HSV), and cytomegalovirus (CMV).
• The majority of Candida esophagitis cases are attributed to C. albicans. Diseases symptomatic of C. glabrata and C. krusei have also been documented.
• Other pathogens that may seldom induce infectious esophagitis include the following:
– Aspergillus species – Histoplasma species – Blastomyces dermatitidis – Varicella zoster virus
– Epstein–Barr virus – Human papillomavirus – Mycobacterium TB and Mycobacterium avium – Normal oropharyngeal flora (rarely) including Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus viridans, and Bacillus species – Acute HIV infection
HISTORY OF DIAGNOSIS
Dysphagia, odynophagia, or both are the most prevalent symptoms.
• Chronic chest pain is also prevalent.
• Additional nonspecific clinical signs, such as weight loss, may arise from these symptoms or indicate an underlying illness responsible for the esophagitis.
Local problems, such as hemorrhage, esophageal perforation, or fistula formation, may arise in the presence of deep esophageal ulcerations caused by infected esophagitis.
Infectious esophagitis might be asymptomatic. The prevalence of asymptomatic esophageal infections is indeterminate.
PHYSICAL EXAMINATION
CMV esophagitis may manifest with systemic symptoms (e.g., fever, nausea, vomiting, or abdominal pain), while Candida and HSV esophagitis typically arise.
Oral lesions. Nonetheless, these sporadic discrepancies are not distinctive. The lack of thrush does not exclude the possibility of Candida esophagitis.
DIAGNOSTIC TESTS AND INTERPRETATION Laboratory
• Hematologic profile • Serological testing for HSV, CMV, and HIV • CMV antigenemia assays or CMV molecular amplification methods
• Brush cytology specimens acquired via endoscopy for the diagnosis of Candida and HSV esophagitis. • Tissue culture for the diagnosis of HSV and CMV esophagitis. Culture is not typically advised for diagnosing Candida esophagitis. This is designated for instances exhibiting clinical characteristics indicative of a pathogen resistant to conventional antifungal treatment.
Imaging
Radiographic assessment following a barium swallow reveals an uneven, frayed look of the esophagus mucosa in instances of Candida esophagitis. At times, the image is indistinguishable from that observed in instances of HSV and CMV esophagitis.
Diagnostic Procedures/Other • Endoscopy and tissue sampling for histological evaluation or brush cytology.
The standard endoscopic presentation of Candida esophagitis features white plaques on the mucosa that frequently hemorrhage upon removal by the endoscope.
Endoscopy in HSV esophagitis demonstrates tiny, well-defined ulcers with a yellowish base. The esophageal mucosa between lesions may frequently appear normal. Shallow, elongated ulcerations, encircled by seemingly normal mucosa, may characterize the endoscopic presentation of CMV esophagitis. Nevertheless, the endoscopic characteristics of Candida, HSV, or CMV esophagitis may be indistinguishable.
Pathological Observations
• Endoscopic tissue specimens may reveal: – Budding yeast cells, hyphae, or pseudohyphae in Candida esophagitis – Multinucleated giant cells and intranuclear inclusion bodies in HSV esophagitis – Cytomegaly of fibroblasts and endothelial cells with intranuclear and cytoplasmic inclusion bodies in
CMV esophagitis.
DIFFERENTIAL DIAGNOSIS
• Esophageal carcinoma (primary or metastatic). • Systemic conditions including: – Crohn's disease
Sarcoidosis
Collagen vascular disorders
Pill esophagitis may occur following the administration of specific antibiotics (such as tetracycline, doxycycline, clindamycin, ciprofloxacin, among others), potassium chloride, nonsteroidal anti-inflammatory medications, and quinidine.
Chemotherapy-induced esophagitis (dactinomycin, bleomycin, cytarabine, methotrexate, and other agents).
• Esophagitis resulting from radiation or the simultaneous application of radiation and chemotherapy.
• Inflammation resulting from sclerotherapy of esophageal varices.
• Idiopathic (aphthous) esophageal ulcers associated with HIV infection.
Oral lesions are frequently observed in patients with Candida and HSV esophagitis, although CMV esophagitis is infrequently linked to stomatitis.
INITIAL THERAPY MEDICATION
Systemic antifungal therapy is invariably necessary for Candida esophagitis (A-II).
A diagnostic trial of antifungal medication is warranted prior to doing an endoscopic examination (B-II).
Oral fluconazole at a dosage of 200–400 mg (3–6 mg/kg) daily for a duration of 14–21 days is advised (A-I). For individuals unable to endure oral therapy: Administer intravenous fluconazole 400 mg (6 mg/kg) daily, deoxycholate amphotericin B 0.3–0.7 mg/kg daily, or an echinocandin (B-II).
For fluconazole-refractory disease: Itraconazole solution 200 mg daily, posaconazole suspension 400 mg twice daily, or voriconazole 200 mg twice daily, taken intravenously or orally for 14–21 days.
• For recurring infections: Administer suppressive therapy with fluconazole at a dosage of 100–200 mg three times weekly (3) (A-I).
• In individuals with AIDS, the use of HAART is advised to mitigate recurring infections (A-I).
HSV esophagitis typically resolves spontaneously in immunocompetent individuals.
Immunocompromised people ought to receive antiviral medications for a duration of 14 to 21 days. Acyclovir 400 mg orally five times daily, valacyclovir 1 g orally three times daily, famciclovir 500 mg orally three times daily. For individuals unable to endure oral therapy: Acyclovir 5 mg/kg intravenously every 8 hours for 7 to 14 days, succeeded by an oral antiviral for a minimum of 1 further week.
Prophylactic therapy with acyclovir at a dosage of 200–400 mg orally per day or 5 mg/kg intravenously twice day may be warranted in cases with elevated risk for HSV reactivation.
CMV esophagitis is managed with ganciclovir at a dosage of 5 mg/kg intravenously twice day for a minimum duration of 2 weeks.
Maintenance therapy with valganciclovir 900 mg orally daily may be required to prevent recurrence of CMV esophagitis in individuals with significant immunocompromise.
To avert CMV infection, CMV seronegative transplant recipients from seropositive donors should undergo antiviral prophylaxis.
Idiopathic (aphthous) esophageal ulcers in HIV infection are managed with prednisone or thalidomide.
Second Line
• For fluconazole-refractory Candida esophagitis: Micafungin 150 mg daily, caspofungin 50 mg daily, anidulafungin 200 mg daily, or deoxycholate
Amphotericin B 0.3–0.7 mg/kg per day (B-II).
• Echinocandins correlate with elevated relapse rates in comparison to fluconazole. • For ganciclovir-resistant HSV or CMV esophagitis: Foscarnet.
INPATIENT CONSIDERATIONS
Criteria for Admission
Outpatient care is suitable unless the patient's immune state is significantly weakened or the infection is exceedingly severe. In such instances, hospitalization may be required.
Intravenous Fluids
Should the patient endure significant odynophagia or if esophagitis is coupled with oral lesions that hinder chewing or swallowing, the provision of intravenous fluids may be requisite.
CONTINUING MANAGEMENT POST-TREATMENT SUGGESTIONS
The anticipated course and prognosis are contingent upon the underlying disease and pathogen; in cases of severe immunosuppression, extended therapy with efficacious drugs is required.
• Patients diagnosed with infectious esophagitis should schedule a follow-up appointment two weeks post-symptom resolution. • The majority of patients with Candida esophagitis typically experience symptom clearance within seven days of initiating treatment.
Myelosuppression is the primary adverse effect of ganciclovir therapy. The simultaneous use of zidovudine may exacerbate myelosuppression.
COMPLICATIONS
• Complications are rare. Severe local consequences may arise from deep esophageal ulcers, including massive hemorrhage.
– Esophageal perforation – Esophagobronchial or esophagomediastinal fistulas
- Published on
Symptoms and Signs – Differential Diagnosis of Oral Lesions
Mouth lesions encompass ulcers (the predominant kind), cysts, solid nodules, hemorrhagic lesions, papules, vesicles, bullae, and erythematous lesions. They can manifest in any location on the lips, cheeks, hard and soft palate, salivary glands, tongue, gingivae, or mucous membranes. Numerous instances are excruciating and can be easily identified. Some individuals are asymptomatic; when located deep within the oral cavity, they may be identified alone by a comprehensive oral examination. Refer to Common Mouth Lesions, page 468. Oral lesions may arise from trauma, infection, systemic illness, substance abuse, or radiation treatment.
Medical History and Physical Assessment
Commence your assessment with a comprehensive history. Inquire with the patient on the onset of the lesions and whether he has observed any pain, odor, or discharge. Inquire about related symptoms, especially skin problems. Acquire a comprehensive drug history, encompassing food and drug allergies as well as antibiotic usage, alongside a thorough medical history. Particularly note cancer, sexually transmitted infections, intravenous drug use, recent infections, or trauma. Inquire about his dental history, encompassing oral hygiene practices, the frequency of dental check-ups, and the date of his latest dental appointment.
Subsequently, conduct a thorough oral examination, documenting the locations and characteristics of lesions. Assess the patient's lips for hue and texture. Examine and palpate the buccal mucosa and tongue for color, texture, and contour; particularly observe for painless ulcers on the lateral aspects or base of the tongue. Secure the tongue with a gauze strip, elevate it, and inspect its ventral surface and the oral floor. Depress the tongue using a tongue blade and inspect the oropharynx. Examine the teeth and gums, observing for absent, fractured, or stained teeth; dental caries; excessive debris; and bleeding, inflamed, swollen, or discolored gums.
Examine the neck for adenopathy, particularly in individuals who smoke tobacco or use alcohol excessively.
Etiological Factors in Medicine
Acquired Immunodeficiency Syndrome (AIDS)
Oral lesions may serve as an early indicator of the immunosuppression characteristic of AIDS. Fungal infections may arise, with oral candidiasis being the most prevalent. Infections caused by bacteria or viruses may affect the oral mucosa, tongue, gingivae, and periodontal tissue.
Kaposi's sarcoma is the principal oral neoplasm linked to AIDS.
The tumor is typically located on the hard palate and may first present as an asymptomatic, flat or elevated lesion, exhibiting colors from red to blue to purple. As these tumors proliferate, they may undergo ulceration and induce pain. Cervicofacial actinomycosis. Actinomycosis is a persistent fungal infection that generally manifests as tiny, hard, flat, and frequently painless nodules on the oral mucosa and subcutaneously in the jaw and neck regions. Swelling may harden and form abscesses, resulting in fistulas and sinus tracts that exhibit a distinctive purulent yellow discharge.
Behçet's syndrome
Behçet’s syndrome is a chronic, progressive condition predominantly affecting young guys, characterized by the formation of tiny, painful ulcers on the lips, gums, buccal mucosa, and tongue. In extreme instances, the ulcers may also manifest on the palate, pharynx, and esophagus. The ulcers generally exhibit an erythematous margin and are coated with a gray or yellow discharge. Comparable lesions manifest on the scrotum and penis or labia majora; diminutive pustules or papules on the torso and extremities; and painful erythematous nodules on the shins. Ocular lesions may also manifest.
Candidiasis
Candidiasis is a prevalent fungal illness that typically manifests as soft, raised plaques on the buccal mucosa, tongue, and occasionally the palate, gingivae, and floor of the mouth; these plaques can be removed by wiping. The lesions of acute atrophic candidiasis are erythematous and unpleasant. The lesions of chronic hyperplastic candidiasis are characterized by a white and hard appearance. Localized regions of erythema, itching, and an unpleasant odor may be evident.
Discoid lupus erythematosus
Oral lesions frequently manifest on the tongue, buccal mucosa, and palate as erythematous regions including white patches and radiating white striae. Accompanying findings consist of facial skin lesions, perhaps extending to the neck, ears, and scalp; involvement of the scalp may lead to alopecia. Hair follicles are dilated and loaded with scales.
This persistent, recurrent condition predominantly affects women aged 30 to 40.
Erythema multiforme.
Erythema multiforme is an acute inflammatory dermatosis characterized by the abrupt emergence of vesicles and bullae on the lips and oral mucosa. Erythematous macules and papules develop symmetrically on the hands, arms, feet, legs, face, and neck, and may even appear in the eyes and on the genitalia. Lymphadenopathy may also manifest. Accompanied by visceral involvement, additional manifestations encompass fever, malaise, cough, pharyngeal and thoracic discomfort, emesis, diarrhea, myalgia, arthralgia, onycholysis, blindness, hematuria, and indications of renal failure.
Acute necrotizing ulcerative gingivitis.
Gingivitis is a recurrent periodontal disorder characterized by the abrupt emergence of gingival ulcers enveloped in a grayish-white pseudomembrane. Additional findings including sore or painful gums, sporadic gingival hemorrhage, halitosis, cervical lymphadenopathy, and pyrexia.
Herpes simplex virus type 1
During primary infection, a short phase of prodromal tingling and pruritus occurs, accompanied by fever and pharyngitis, followed by the emergence of tiny, irritating vesicles on the oral mucosa, particularly affecting the tongue, gums, and cheeks. Vesicles develop on an erythematous foundation and then burst, resulting in a painful ulcer, which is then covered by a yellowish crust. Additional observations comprise submaxillary lymphadenopathy, hyper salivation, halitosis, anorexia, and keratoconjunctivitis.
Herpes zoster
Herpes zoster is a prevalent viral illness that can generate painful lesions on the buccal mucosa, tongue, uvula, pharynx, and larynx. Small red nodules generally appear unilaterally on the thorax or vertically on the arms and legs, quickly transforming into vesicles containing clear fluid or pus; these vesicles desiccate and develop scabs approximately 10 days post-eruption. A fever and general malaise are present alongside pruritus, paresthesia or hyperesthesia, and soreness along the affected sensory nerve pathway.
Inflammatory fibrous hyperplasia. Inflammatory fibrous hyperplasia is a painless nodular enlargement of the buccal mucosa, usually caused by trauma or irritation to the cheek, and is distinguished by pink, smooth, pedunculated soft tissue regions.
Leukoplakia with erythroplakia
Leukoplakia is a white lesion that cannot be eliminated merely by abrasive contact with the mucosal surface, in contrast to candidiasis. It may arise because to persistent irritation from dentures or tobacco or pipe smoking, or it may indicate dysplasia or early squamous cell cancer.
Erythroplakia presents as red, edematous tissue with a velvety texture. Approximately 90% of erythroplakia patients are classified as either dysplasia or carcinoma.
Benign mucosal pemphigoid
Pemphigoid is an uncommon autoimmune disorder characterized by thick-walled vesicles on the oral mucosa, conjunctiva, and, less frequently, the skin. Mouth lesions often arise months or even years prior to other symptoms and may present as desquamative patchy gingivitis or as a vesicobullous eruption. Secondary fibrous bands can result in dysphagia, hoarseness, and blindness. Recurrent dermatological lesions consist of vesicobullous eruptions, typically located in the inguinal region and extremities, as well as an erythematous, vesicobullous plaque on the scalp and face adjacent to the affected mucous membranes.
Pemphigus.
Pemphigus is a chronic dermatological condition characterized by the cyclical formation of thin-walled vesicles and bullae on otherwise normal skin or mucous membranes. Bullae on the oral mucosa rupture, resulting in painful sores and easily bleeding raw areas. Accompanying observations consist of bullae located across the body, skin denudation, and pruritus.
Pyogenic granuloma.
Pyogenic granuloma, sometimes resulting from injury, trauma, or irritation, is characterized by a soft, painful nodule, papule, or polypoid mass of excessive granulated tissue. It typically manifests on the gingivae but may also occur on the lips, tongue, or buccal mucosa. The lesions exhibit a propensity to bleed due to their abundant capillary presence. The impacted region may exhibit a smooth or verrucous texture; erythema manifests in the adjacent mucosa. The lesions may become ulcerated, resulting in a purulent discharge.
Squamous cell carcinoma.
Squamous cell carcinoma is generally characterized by a painless ulcer featuring an elevated, hardened margin. It may manifest in regions of leukoplakia, predominantly on the lower lip, but it can also arise on the lateral borders of the tongue or the floor of the mouth. Chronic smoking and alcohol consumption are high-risk factors.
Aphthous stomatitis.
Stomatitis, a prevalent condition, is marked by painful ulcerations of the oral mucosa, typically affecting the dorsum of the tongue, gingivae, and hard palate.
In recurrent aphthous stomatitis minor, the ulcer initiates as one or more erosions enveloped by a gray membrane and encircled by a crimson halo. It is typically located on the buccal and labial mucosa and junction, tongue, soft palate, pharynx, gingivae, and all areas not adhered to the periosteum.
In recurrent aphthous stomatitis massive, substantial, painful ulcers frequently occur am if on the lips, cheeks, tongue, and soft palate; they may persist for up to 6 weeks and result in scarring.
Syphilis
Primary syphilis generally manifests as a singular, painless, red ulcer (chancre) on the lip, tongue, palate, tonsil, or gingivae. The ulcer manifests as a crater with undulating, elevated margins and a lustrous core; lip chancres may form a crust. Comparable lesions may manifest on the fingers, breasts, or genitals, and regional lymph nodes may exhibit enlargement and tenderness. In the later stage, numerous painless ulcers, obscured by a grayish-white plaque, may emerge on the tongue, gingiva, or buccal mucosa. A macular, papular, pustular, or nodular rash manifests, typically on the arms, trunk, palms, soles, face, and scalp; genital lesions generally resolve. Additional findings encompass widespread lymphadenopathy, cephalalgia, malaise, anorexia, weight reduction, nausea, emesis, pharyngodynia, low-grade fever, metrorrhagia, and postcoital hemorrhage.
During the tertiary stage, lesions, typically gummas—chronic, painless, superficial nodules or deep granulomatous lesions—emerge on the skin and mucous membranes, particularly affecting the tongue and mouth.
Systemic lupus erythematosus.
Oral lesions sometimes manifest as erythematous regions accompanied by edema, petechiae, and superficial ulcers featuring a red halo and a propensity to bleed. The primary consequences consist of nondeforming arthritis, a butterfly rash on the nose and cheeks, and photosensitivity.
Alternative Causes
Pharmaceuticals. Multiple chemotherapeutic drugs can directly induce stomatitis. Allergic reactions to penicillin, sulfonamides, gold, quinine, streptomycin, phenytoin, aspirin, and barbiturates frequently result in the formation and eruption of lesions. Inhaled corticosteroids utilized for pulmonary conditions may potentially induce mouth lesions.
Radiation treatment. Radiation therapy can induce oral lesions. Particular Considerations
Administer a topical anesthetic, such as lidocaine, if the patient experiences painful mouth ulcers.
Patient Consultation
Identify the irritants the patient should evade and the associated signs and symptoms.
document. Instruct the patient on appropriate oral care and hygiene practices.
Pediatric Guidelines
The etiologies of oral ulcers in pediatric patients encompass chickenpox, measles, scarlet fever, diphtheria, and hand-foot-and-mouth disease. Mouth ulcers in neonates may arise from candidiasis or congenital syphilis.
Mouth lesions encompass ulcers (the predominant kind), cysts, solid nodules, hemorrhagic lesions, papules, vesicles, bullae, and erythematous lesions. They can manifest in any location on the lips, cheeks, hard and soft palate, salivary glands, tongue, gingivae, or mucous membranes. Numerous instances are excruciating and can be easily identified. Some individuals are asymptomatic; when located deep within the oral cavity, they may be identified alone by a comprehensive oral examination. Refer to Common Mouth Lesions, page 468. Oral lesions may arise from trauma, infection, systemic illness, substance abuse, or radiation treatment.
Medical History and Physical Assessment
Commence your assessment with a comprehensive history. Inquire with the patient on the onset of the lesions and whether he has observed any pain, odor, or discharge. Inquire about related symptoms, especially skin problems. Acquire a comprehensive drug history, encompassing food and drug allergies as well as antibiotic usage, alongside a thorough medical history. Particularly note cancer, sexually transmitted infections, intravenous drug use, recent infections, or trauma. Inquire about his dental history, encompassing oral hygiene practices, the frequency of dental check-ups, and the date of his latest dental appointment.
Subsequently, conduct a thorough oral examination, documenting the locations and characteristics of lesions. Assess the patient's lips for hue and texture. Examine and palpate the buccal mucosa and tongue for color, texture, and contour; particularly observe for painless ulcers on the lateral aspects or base of the tongue. Secure the tongue with a gauze strip, elevate it, and inspect its ventral surface and the oral floor. Depress the tongue using a tongue blade and inspect the oropharynx. Examine the teeth and gums, observing for absent, fractured, or stained teeth; dental caries; excessive debris; and bleeding, inflamed, swollen, or discolored gums.
Examine the neck for adenopathy, particularly in individuals who smoke tobacco or use alcohol excessively.
Etiological Factors in Medicine
Acquired Immunodeficiency Syndrome (AIDS)
Oral lesions may serve as an early indicator of the immunosuppression characteristic of AIDS. Fungal infections may arise, with oral candidiasis being the most prevalent. Infections caused by bacteria or viruses may affect the oral mucosa, tongue, gingivae, and periodontal tissue.
Kaposi's sarcoma is the principal oral neoplasm linked to AIDS.
The tumor is typically located on the hard palate and may first present as an asymptomatic, flat or elevated lesion, exhibiting colors from red to blue to purple. As these tumors proliferate, they may undergo ulceration and induce pain. Cervicofacial actinomycosis. Actinomycosis is a persistent fungal infection that generally manifests as tiny, hard, flat, and frequently painless nodules on the oral mucosa and subcutaneously in the jaw and neck regions. Swelling may harden and form abscesses, resulting in fistulas and sinus tracts that exhibit a distinctive purulent yellow discharge.
Behçet's syndrome
Behçet’s syndrome is a chronic, progressive condition predominantly affecting young guys, characterized by the formation of tiny, painful ulcers on the lips, gums, buccal mucosa, and tongue. In extreme instances, the ulcers may also manifest on the palate, pharynx, and esophagus. The ulcers generally exhibit an erythematous margin and are coated with a gray or yellow discharge. Comparable lesions manifest on the scrotum and penis or labia majora; diminutive pustules or papules on the torso and extremities; and painful erythematous nodules on the shins. Ocular lesions may also manifest.
Candidiasis
Candidiasis is a prevalent fungal illness that typically manifests as soft, raised plaques on the buccal mucosa, tongue, and occasionally the palate, gingivae, and floor of the mouth; these plaques can be removed by wiping. The lesions of acute atrophic candidiasis are erythematous and unpleasant. The lesions of chronic hyperplastic candidiasis are characterized by a white and hard appearance. Localized regions of erythema, itching, and an unpleasant odor may be evident.
Discoid lupus erythematosus
Oral lesions frequently manifest on the tongue, buccal mucosa, and palate as erythematous regions including white patches and radiating white striae. Accompanying findings consist of facial skin lesions, perhaps extending to the neck, ears, and scalp; involvement of the scalp may lead to alopecia. Hair follicles are dilated and loaded with scales.
This persistent, recurrent condition predominantly affects women aged 30 to 40.
Erythema multiforme.
Erythema multiforme is an acute inflammatory dermatosis characterized by the abrupt emergence of vesicles and bullae on the lips and oral mucosa. Erythematous macules and papules develop symmetrically on the hands, arms, feet, legs, face, and neck, and may even appear in the eyes and on the genitalia. Lymphadenopathy may also manifest. Accompanied by visceral involvement, additional manifestations encompass fever, malaise, cough, pharyngeal and thoracic discomfort, emesis, diarrhea, myalgia, arthralgia, onycholysis, blindness, hematuria, and indications of renal failure.
Acute necrotizing ulcerative gingivitis.
Gingivitis is a recurrent periodontal disorder characterized by the abrupt emergence of gingival ulcers enveloped in a grayish-white pseudomembrane. Additional findings including sore or painful gums, sporadic gingival hemorrhage, halitosis, cervical lymphadenopathy, and pyrexia.
Herpes simplex virus type 1
During primary infection, a short phase of prodromal tingling and pruritus occurs, accompanied by fever and pharyngitis, followed by the emergence of tiny, irritating vesicles on the oral mucosa, particularly affecting the tongue, gums, and cheeks. Vesicles develop on an erythematous foundation and then burst, resulting in a painful ulcer, which is then covered by a yellowish crust. Additional observations comprise submaxillary lymphadenopathy, hyper salivation, halitosis, anorexia, and keratoconjunctivitis.
Herpes zoster
Herpes zoster is a prevalent viral illness that can generate painful lesions on the buccal mucosa, tongue, uvula, pharynx, and larynx. Small red nodules generally appear unilaterally on the thorax or vertically on the arms and legs, quickly transforming into vesicles containing clear fluid or pus; these vesicles desiccate and develop scabs approximately 10 days post-eruption. A fever and general malaise are present alongside pruritus, paresthesia or hyperesthesia, and soreness along the affected sensory nerve pathway.
Inflammatory fibrous hyperplasia. Inflammatory fibrous hyperplasia is a painless nodular enlargement of the buccal mucosa, usually caused by trauma or irritation to the cheek, and is distinguished by pink, smooth, pedunculated soft tissue regions.
Leukoplakia with erythroplakia
Leukoplakia is a white lesion that cannot be eliminated merely by abrasive contact with the mucosal surface, in contrast to candidiasis. It may arise because to persistent irritation from dentures or tobacco or pipe smoking, or it may indicate dysplasia or early squamous cell cancer.
Erythroplakia presents as red, edematous tissue with a velvety texture. Approximately 90% of erythroplakia patients are classified as either dysplasia or carcinoma.
Benign mucosal pemphigoid
Pemphigoid is an uncommon autoimmune disorder characterized by thick-walled vesicles on the oral mucosa, conjunctiva, and, less frequently, the skin. Mouth lesions often arise months or even years prior to other symptoms and may present as desquamative patchy gingivitis or as a vesicobullous eruption. Secondary fibrous bands can result in dysphagia, hoarseness, and blindness. Recurrent dermatological lesions consist of vesicobullous eruptions, typically located in the inguinal region and extremities, as well as an erythematous, vesicobullous plaque on the scalp and face adjacent to the affected mucous membranes.
Pemphigus.
Pemphigus is a chronic dermatological condition characterized by the cyclical formation of thin-walled vesicles and bullae on otherwise normal skin or mucous membranes. Bullae on the oral mucosa rupture, resulting in painful sores and easily bleeding raw areas. Accompanying observations consist of bullae located across the body, skin denudation, and pruritus.
Pyogenic granuloma.
Pyogenic granuloma, sometimes resulting from injury, trauma, or irritation, is characterized by a soft, painful nodule, papule, or polypoid mass of excessive granulated tissue. It typically manifests on the gingivae but may also occur on the lips, tongue, or buccal mucosa. The lesions exhibit a propensity to bleed due to their abundant capillary presence. The impacted region may exhibit a smooth or verrucous texture; erythema manifests in the adjacent mucosa. The lesions may become ulcerated, resulting in a purulent discharge.
Squamous cell carcinoma.
Squamous cell carcinoma is generally characterized by a painless ulcer featuring an elevated, hardened margin. It may manifest in regions of leukoplakia, predominantly on the lower lip, but it can also arise on the lateral borders of the tongue or the floor of the mouth. Chronic smoking and alcohol consumption are high-risk factors.
Aphthous stomatitis.
Stomatitis, a prevalent condition, is marked by painful ulcerations of the oral mucosa, typically affecting the dorsum of the tongue, gingivae, and hard palate.
In recurrent aphthous stomatitis minor, the ulcer initiates as one or more erosions enveloped by a gray membrane and encircled by a crimson halo. It is typically located on the buccal and labial mucosa and junction, tongue, soft palate, pharynx, gingivae, and all areas not adhered to the periosteum.
In recurrent aphthous stomatitis massive, substantial, painful ulcers frequently occur am if on the lips, cheeks, tongue, and soft palate; they may persist for up to 6 weeks and result in scarring.
Syphilis
Primary syphilis generally manifests as a singular, painless, red ulcer (chancre) on the lip, tongue, palate, tonsil, or gingivae. The ulcer manifests as a crater with undulating, elevated margins and a lustrous core; lip chancres may form a crust. Comparable lesions may manifest on the fingers, breasts, or genitals, and regional lymph nodes may exhibit enlargement and tenderness. In the later stage, numerous painless ulcers, obscured by a grayish-white plaque, may emerge on the tongue, gingiva, or buccal mucosa. A macular, papular, pustular, or nodular rash manifests, typically on the arms, trunk, palms, soles, face, and scalp; genital lesions generally resolve. Additional findings encompass widespread lymphadenopathy, cephalalgia, malaise, anorexia, weight reduction, nausea, emesis, pharyngodynia, low-grade fever, metrorrhagia, and postcoital hemorrhage.
During the tertiary stage, lesions, typically gummas—chronic, painless, superficial nodules or deep granulomatous lesions—emerge on the skin and mucous membranes, particularly affecting the tongue and mouth.
Systemic lupus erythematosus.
Oral lesions sometimes manifest as erythematous regions accompanied by edema, petechiae, and superficial ulcers featuring a red halo and a propensity to bleed. The primary consequences consist of nondeforming arthritis, a butterfly rash on the nose and cheeks, and photosensitivity.
Alternative Causes
Pharmaceuticals. Multiple chemotherapeutic drugs can directly induce stomatitis. Allergic reactions to penicillin, sulfonamides, gold, quinine, streptomycin, phenytoin, aspirin, and barbiturates frequently result in the formation and eruption of lesions. Inhaled corticosteroids utilized for pulmonary conditions may potentially induce mouth lesions.
Radiation treatment. Radiation therapy can induce oral lesions. Particular Considerations
Administer a topical anesthetic, such as lidocaine, if the patient experiences painful mouth ulcers.
Patient Consultation
Identify the irritants the patient should evade and the associated signs and symptoms.
document. Instruct the patient on appropriate oral care and hygiene practices.
Pediatric Guidelines
The etiologies of oral ulcers in pediatric patients encompass chickenpox, measles, scarlet fever, diphtheria, and hand-foot-and-mouth disease. Mouth ulcers in neonates may arise from candidiasis or congenital syphilis.
- Published on
Symptoms and Signs – Differential Diagnosis of Muscle Atrophy [Muscle Wasting]
Muscle atrophy occurs due to denervation or extended disuse of the muscle. In the absence of regular exercise, muscle fibers atrophy in both volume and length, resulting in a noticeable reduction in muscle size and definition, as well as observable emaciation or distortion in the affected region. Even minimal atrophy typically results in a reduction of mobility or strength.
Atrophy typically arises from neuromuscular disorders or trauma. Nonetheless, it may also arise from specific metabolic and endocrine diseases, as well as extended immobility. Muscle atrophy also occurs with aging.
Medical History and Physical Assessment
Inquire of the patient regarding the initial onset and location of the muscular atrophy, as well as its progression over time. Inquire about concomitant signs and symptoms, including weakness, discomfort, loss of sensation, and recent weight loss. Examine the patient's medical history for chronic illnesses, musculoskeletal or neurological issues, including trauma, as well as endocrine and metabolic abnormalities. Inquire about his consumption of alcohol and drugs, with a specific focus on steroids.
Commence the physical examination by assessing the site and degree of atrophy. Conduct a visual assessment of both minor and major muscle groups. Assess all primary muscular groups for hypertrophy, tonicity, and strength. Refer to Testing Muscle Strength, pages 488 and 489. Assess the circumference of all extremities, contrasting both sides. Refer to the measurement of limb circumference. Assess for muscle contractures in all extremities by completely stretching the joints and observing for pain or resistance. Conclude the examination by palpating peripheral pulses for quality and rate, evaluating sensory function in and around the atrophied region, and examining deep tendon reflexes (DTRs).
Etiological Factors
Amyotrophic lateral sclerosis (ALS). The initial manifestations of ALS consist of muscle weakness and atrophy, which generally commence in one hand, extend to the corresponding arm, and then affect the contralateral hand and arm. Ultimately, weakness and atrophy disseminate to the trunk, neck, tongue, larynx, pharynx, and legs; advancing respiratory muscle weakness results in respiratory insufficiency. Additional observations encompass muscle flaccidity, fasciculations, hyperactive deep tendon reflexes, mild leg muscle spasticity, dysphagia, poor speech, excessive salivation, and sadness.
Incendiary injuries. The creation of fibrous scar tissue, discomfort, and depletion of serum proteins due to severe burns can restrict muscle activity, leading to atrophy. Hypothyroidism. Hypothyroidism may result in reversible weakening and atrophy of proximal limb muscles. Commonly associated observations include muscle cramps and rigidity; cold sensitivity; weight gain despite starvation; cognitive sluggishness; dry, pale, chilly, and doughy skin; facial, hand, and foot edema; and bradycardia.
Meniscal rupture. Quadriceps muscle atrophy, caused by extended knee immobility and muscular weakening, is a characteristic indication of a meniscal rupture, a traumatic injury.
Multiple sclerosis. Multiple sclerosis is a degenerative condition that can lead to atrophy of the arms and legs due to persistent increasing weakness.
Spasticity and contractures may also arise. Commonly associated signs and symptoms fluctuate and encompass diplopia, blurred vision, nystagmus, hyperactive deep tendon reflexes, sensory loss or paresthesia, dysarthria, dysphagia, incoordination, ataxic gait, intention tremors, emotional lability, impotence, and urine dysfunction.
GUIDELINE FOR ASSESSING LIMB CIRCUMFERENCE To guarantee precise and uniform limb circumference measurements, designate and utilize a constant reference point for each measurement, ensuring the limb is fully extended during the process. The picture below depicts the accurate reference points for measuring arms and legs.
Osteoarthritis
Osteoarthritis is a chronic condition that ultimately leads to atrophy next to affected joints due to gradual weakening and neglect. Additional late signs and symptoms encompass osseous joint abnormalities, including Heberden’s nodes on the distal interphalangeal joints, Bouchard’s nodes on the proximal interphalangeal joints, crepitus, fluid accumulation, and contractures.
Parkinson's disease. In Parkinson's disease, muscle rigidity, weakness, and inactivity can lead to muscle atrophy. The patient may display gradual resting tremors, typically commencing in the fingers (pill-rolling tremor), exacerbated by tension, and alleviated by intentional movement and sleep. He may also exhibit bradykinesia, a distinctive propulsive walk, and a high-pitched voice.
Monotonous voice; mask-like facial expression; drooling; dysphagia; dysarthria; and, infrequently, oculogyric crisis or blepharospasm.
Peripheral neuropathy. Peripheral neuropathy leads to a gradual progression of muscle weakening to flaccid paralysis and ultimately atrophy. The muscles of the distal extremities are typically the first to be impacted. Accompanying symptoms include of impaired vibration perception; paresthesia, hyperesthesia, or anesthesia in the extremities; mild to intense burning pain; anhidrosis; shiny red skin; and reduced or absent deep tendon reflexes.
Insufficient protein intake. Chronic protein shortage may result in muscular weakening and atrophy. Additional observations encompass persistent weariness, apathy, anorexia, xerosis, peripheral edema, and dull, thin, brittle hair. Rheumatoid arthritis. Muscle atrophy manifests in the advanced stages of rheumatoid arthritis due to joint discomfort and stiffness, which diminish range of motion (ROM) and inhibit muscle utilization.
Spinal cord damage
Spinal cord trauma can result in significant muscle weakness and flaccid paralysis, which may progress to spastic paralysis, ultimately causing atrophy. Additional signs and symptoms vary according to the severity of the lesion and may encompass respiratory insufficiency or paralysis, sensory deficits, bowel and bladder dysfunction, hyperactive deep tendon reflexes, a positive Babinski response, sexual dysfunction, priapism, hypotension, and unilateral anhidrosis.
Additional Causes: Substances. Extended steroid treatment disrupts muscle metabolism and results in atrophy, particularly in the extremities.
Inertia. Extended immobility due to bed rest, casts, splints, or traction can result in muscular weakening and atrophy.
Particular Considerations
To prevent contractures resulting from the shortening of atrophied muscle fibers, assist the patient in preserving muscle length by promoting frequent active range of motion exercises. If he is unable to actively mobilize a joint, administer active assistive or passive exercises, and utilize splints or braces to preserve muscle length. In the event of encountering resistance to full extension during exercise, employ heat, analgesics, or relaxation techniques to alleviate muscle tension. Gradually extend it to its full length. (Warning: Avoid pulling or straining the muscle, as this may result in the tearing of muscle fibers and exacerbate contracture.) If these methods do not rectify the contracture, employ moist heat, a whirlpool bath, resistive exercises, or ultrasound therapy. If
If these approaches prove ineffective, surgical release of contractures may be required.
Instruct the patient on the right utilization of essential assistive equipment to guarantee safety and mitigate the risk of falls. Advise the patient to consult a physical therapist for a tailored therapeutic regimen.
Prepare the patient for electromyography, nerve conduction investigations, muscle biopsies, and X-rays or computed tomography scans.
Patient Consultation
Instruct the patient on the utilization of assistive devices as necessary, while underscoring the safety protocols he should implement. Instruct the patient on a prescribed workout routine to adhere to.
Pediatric Guidelines
In early children, muscular dystrophy can lead to significant muscle weakening and atrophy. Muscle atrophy may also arise from cerebral palsy, poliomyelitis, and paralysis linked to meningocele and myelomeningocele.
Muscle atrophy occurs due to denervation or extended disuse of the muscle. In the absence of regular exercise, muscle fibers atrophy in both volume and length, resulting in a noticeable reduction in muscle size and definition, as well as observable emaciation or distortion in the affected region. Even minimal atrophy typically results in a reduction of mobility or strength.
Atrophy typically arises from neuromuscular disorders or trauma. Nonetheless, it may also arise from specific metabolic and endocrine diseases, as well as extended immobility. Muscle atrophy also occurs with aging.
Medical History and Physical Assessment
Inquire of the patient regarding the initial onset and location of the muscular atrophy, as well as its progression over time. Inquire about concomitant signs and symptoms, including weakness, discomfort, loss of sensation, and recent weight loss. Examine the patient's medical history for chronic illnesses, musculoskeletal or neurological issues, including trauma, as well as endocrine and metabolic abnormalities. Inquire about his consumption of alcohol and drugs, with a specific focus on steroids.
Commence the physical examination by assessing the site and degree of atrophy. Conduct a visual assessment of both minor and major muscle groups. Assess all primary muscular groups for hypertrophy, tonicity, and strength. Refer to Testing Muscle Strength, pages 488 and 489. Assess the circumference of all extremities, contrasting both sides. Refer to the measurement of limb circumference. Assess for muscle contractures in all extremities by completely stretching the joints and observing for pain or resistance. Conclude the examination by palpating peripheral pulses for quality and rate, evaluating sensory function in and around the atrophied region, and examining deep tendon reflexes (DTRs).
Etiological Factors
Amyotrophic lateral sclerosis (ALS). The initial manifestations of ALS consist of muscle weakness and atrophy, which generally commence in one hand, extend to the corresponding arm, and then affect the contralateral hand and arm. Ultimately, weakness and atrophy disseminate to the trunk, neck, tongue, larynx, pharynx, and legs; advancing respiratory muscle weakness results in respiratory insufficiency. Additional observations encompass muscle flaccidity, fasciculations, hyperactive deep tendon reflexes, mild leg muscle spasticity, dysphagia, poor speech, excessive salivation, and sadness.
Incendiary injuries. The creation of fibrous scar tissue, discomfort, and depletion of serum proteins due to severe burns can restrict muscle activity, leading to atrophy. Hypothyroidism. Hypothyroidism may result in reversible weakening and atrophy of proximal limb muscles. Commonly associated observations include muscle cramps and rigidity; cold sensitivity; weight gain despite starvation; cognitive sluggishness; dry, pale, chilly, and doughy skin; facial, hand, and foot edema; and bradycardia.
Meniscal rupture. Quadriceps muscle atrophy, caused by extended knee immobility and muscular weakening, is a characteristic indication of a meniscal rupture, a traumatic injury.
Multiple sclerosis. Multiple sclerosis is a degenerative condition that can lead to atrophy of the arms and legs due to persistent increasing weakness.
Spasticity and contractures may also arise. Commonly associated signs and symptoms fluctuate and encompass diplopia, blurred vision, nystagmus, hyperactive deep tendon reflexes, sensory loss or paresthesia, dysarthria, dysphagia, incoordination, ataxic gait, intention tremors, emotional lability, impotence, and urine dysfunction.
GUIDELINE FOR ASSESSING LIMB CIRCUMFERENCE To guarantee precise and uniform limb circumference measurements, designate and utilize a constant reference point for each measurement, ensuring the limb is fully extended during the process. The picture below depicts the accurate reference points for measuring arms and legs.
Osteoarthritis
Osteoarthritis is a chronic condition that ultimately leads to atrophy next to affected joints due to gradual weakening and neglect. Additional late signs and symptoms encompass osseous joint abnormalities, including Heberden’s nodes on the distal interphalangeal joints, Bouchard’s nodes on the proximal interphalangeal joints, crepitus, fluid accumulation, and contractures.
Parkinson's disease. In Parkinson's disease, muscle rigidity, weakness, and inactivity can lead to muscle atrophy. The patient may display gradual resting tremors, typically commencing in the fingers (pill-rolling tremor), exacerbated by tension, and alleviated by intentional movement and sleep. He may also exhibit bradykinesia, a distinctive propulsive walk, and a high-pitched voice.
Monotonous voice; mask-like facial expression; drooling; dysphagia; dysarthria; and, infrequently, oculogyric crisis or blepharospasm.
Peripheral neuropathy. Peripheral neuropathy leads to a gradual progression of muscle weakening to flaccid paralysis and ultimately atrophy. The muscles of the distal extremities are typically the first to be impacted. Accompanying symptoms include of impaired vibration perception; paresthesia, hyperesthesia, or anesthesia in the extremities; mild to intense burning pain; anhidrosis; shiny red skin; and reduced or absent deep tendon reflexes.
Insufficient protein intake. Chronic protein shortage may result in muscular weakening and atrophy. Additional observations encompass persistent weariness, apathy, anorexia, xerosis, peripheral edema, and dull, thin, brittle hair. Rheumatoid arthritis. Muscle atrophy manifests in the advanced stages of rheumatoid arthritis due to joint discomfort and stiffness, which diminish range of motion (ROM) and inhibit muscle utilization.
Spinal cord damage
Spinal cord trauma can result in significant muscle weakness and flaccid paralysis, which may progress to spastic paralysis, ultimately causing atrophy. Additional signs and symptoms vary according to the severity of the lesion and may encompass respiratory insufficiency or paralysis, sensory deficits, bowel and bladder dysfunction, hyperactive deep tendon reflexes, a positive Babinski response, sexual dysfunction, priapism, hypotension, and unilateral anhidrosis.
Additional Causes: Substances. Extended steroid treatment disrupts muscle metabolism and results in atrophy, particularly in the extremities.
Inertia. Extended immobility due to bed rest, casts, splints, or traction can result in muscular weakening and atrophy.
Particular Considerations
To prevent contractures resulting from the shortening of atrophied muscle fibers, assist the patient in preserving muscle length by promoting frequent active range of motion exercises. If he is unable to actively mobilize a joint, administer active assistive or passive exercises, and utilize splints or braces to preserve muscle length. In the event of encountering resistance to full extension during exercise, employ heat, analgesics, or relaxation techniques to alleviate muscle tension. Gradually extend it to its full length. (Warning: Avoid pulling or straining the muscle, as this may result in the tearing of muscle fibers and exacerbate contracture.) If these methods do not rectify the contracture, employ moist heat, a whirlpool bath, resistive exercises, or ultrasound therapy. If
If these approaches prove ineffective, surgical release of contractures may be required.
Instruct the patient on the right utilization of essential assistive equipment to guarantee safety and mitigate the risk of falls. Advise the patient to consult a physical therapist for a tailored therapeutic regimen.
Prepare the patient for electromyography, nerve conduction investigations, muscle biopsies, and X-rays or computed tomography scans.
Patient Consultation
Instruct the patient on the utilization of assistive devices as necessary, while underscoring the safety protocols he should implement. Instruct the patient on a prescribed workout routine to adhere to.
Pediatric Guidelines
In early children, muscular dystrophy can lead to significant muscle weakening and atrophy. Muscle atrophy may also arise from cerebral palsy, poliomyelitis, and paralysis linked to meningocele and myelomeningocele.